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University of Namur 
Faculty of Sciences 
Rue de Bruxelles 61, B-5000 Namur, Belgique 
Structural characterization of cyclodextrins: from inclusion 
complexes to Metal-Organic Frameworks (MOFs) 
By Kossay Elasaad 
Summary 
Cyclodextrins (CD) are cyclic oligosaccharides composed of six to more than sixty glucose units. 
α-CD, β-CD and γ-CD are well known CD consisting of 6, 7 and 8 glycopyranose units, 
respectively, that are torus-like rings built up from glycopyranose units. The secondary hydroxyl 
groups are situated on one of the two edges of the ring, whereas all the primary ones are placed 
on the other edge. The ring is a conical cylinder, which is frequently characterized as a doughnut 
or wreath shaped truncated cone. The cavity is lined with hydrogen atoms and glycosidic oxygen 
bridges, respectively. The primary and secondary hydroxyls on the outside of the cyclodextrins 
make cyclodextrins water-soluble. The cavity of the cyclodextrin consists of a ring of C-H 
groups, a ring of glycosidic oxygen atoms and again a ring of C-H groups. This renders the 
interior of the cyclodextrin rings less polar. As a consequence, the hydrophilic sites which are 
outside of the torus enable CD to be soluble in water, whereas the apolar cavity site which 
provides a hydrophobic matrix, enables CD to form inclusion complex with a variety of 
hydrophobic guest molecules. In addition, CD contains repeating units of ‒OCCO‒ binding 
motif on both their primary and secondary faces. This makes CD able to form extended 
structures with metal cations of Group IA and IIA (MOFs).  
The main goal of this thesis was to design, prepare and characterize new crystal systems based 
on cyclodextrins properties in combination with: 
1. Para aminobenzoic acid (pABA) as a drug model to study the effect of complexation 
phenomena on the solubility of drugs. Their structure and mode of interaction were 
characterized by combination a theoretical and experimental approaches.  
2. Potassium hydroxide to prepare cyclodextrin Metal-Organic Frameworks (CD-MOFs) 
formed by coordinating the cyclodextrins to potassium cation. Consequently, taking the 
advantages of this interaction between cyclodextrin and alkali metal cation, formation of 
inclusion complexes as CD-MOFs drug carrier was favored.   
3. Aegelinol, a natural product, for analytical purposes to determine the absolute configuration 
of this compound by formation of an inclusion complex with a host of known chirality 
(cyclodextrins consists of several optically active D-glucose units). This should allow direct 
determination of the absolute configuration of the guest (aegelinol). 
 
PhD thesis in Chemistry 
18 December 2013 
Research Unit in Physico Chemistry, Laboratory of Structural Biological Chemistry  
Promoter: Prof. Johan Wouters  
- 4 - 
 
Université de Namur 
Faculté des sciences 
Rue de Bruxelles 61, B-5000 Namur, Belgique 
Caractérisation structurale de cyclodextrines: de complexes 
d'inclusion aux architectures métallo-organiques (MOFs) 
Par Kossay Elasaad 
Résumé 
Les cyclodextrines (CD) sont des oligosaccharides cycliques composés de six à plus de soixante 
unités de glucose. Les α-CD, β-CD et γ-CD sont des CD bien connues composées de 6, 7 et 8 
unités glycopyranose, respectivement, qui sont en forme d’anneaux construits à partir d'unités 
glycopyranose.  Les groupes hydroxyles secondaires sont situés sur l'un des deux bords de 
l'anneau, alors que tous les groupes hydroxyles primaires sont placés sur l'autre bord. L'anneau 
est un cylindre conique, qui est souvent décrit comme un beignet ou une couronne en forme de 
cône tronqué. La cavité est bordée par des atomes d'hydrogène et des oxygènes de ponts 
glycosidiques, respectivement. Les groupes hydroxyle primaires et secondaires à l'extérieur des 
cyclodextrines les rendent solubles dans l'eau. La cavité de la cyclodextrine se compose d'un 
anneau de groupes CH, un cycle d'atomes d'oxygène glycosidiques et encore une bague de 
groupes CH. Ceci rend l'intérieur des anneaux de cyclodextrine moins polaire. En conséquence, 
les sites hydrophiles qui sont à l'extérieur du tore rendent les CD solubles dans l'eau, tandis que 
le site de la cavité apolaire fournit une matrice hydrophobe qui permet aux CD de former un 
complexe d'inclusion avec une variété de molécules hôtes hydrophobes. En outre, les CD 
contiennent des motifs répétitifs ‒OCCO‒ de liaison sur leurs deux faces primaires et 
secondaires. Cela rend les CD capables de former des structures étendues avec des cations 
métalliques de groupe IA et IIA (MOF). 
L'objectif principal de cette thèse était de concevoir, préparer et caractériser de nouveaux 
systèmes cristallins basés sur les propriétés des cyclodextrines en combinaison avec: 
1. para-Aminobenzoïque (pABA) comme un modèle de drogue pour étudier l'effet des 
phénomènes de complexation sur la solubilité des médicaments et de caractériser leur structure et 
leur mode d'interaction par la combinaison d'une approche théorique et expérimentale. 
2. L'hydroxyde de potassium pour préparer des cyclodextrines à architecture métallo-organiques 
(CD-MOF) formée par la coordination des cyclodextrines au cation potassium. Les avantages de 
cette interaction entre la cyclodextrine et le cation de métal alcalin ont été exploités pour 
favoriser la formation de complexes d'inclusion comme vecteur potentiel de médicament. 
3. L’aegelinol, un produit naturel, à des fins d'analyse afin de déterminer la configuration absolue 
de ce composé par la formation d'un complexe d'inclusion avec un hôte de chiralité connue (une 
cyclodextrine se compose de plusieurs unités de D-glucose optiquement actifs). Cela devrait 
permettre de déterminer directement la configuration absolue de l'invité (aegelinol).  
Thèse de doctorat en Sciences Chimiques 
18 Decembre 2013 
Unité de Recherche en Chimie Physique, Laboratoire de Chimie Biologique Structurale 
Promoteur: Prof. Johan Wouters   
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Chapter 1 
Introduction 
Abstract 
This chapter starts with a general historical overview of the discovery of 
cyclodextrins. Then the structure and some physical properties of cyclodextrins 
(CDs) are reviewed. 
Due to their structure and physical properties cyclodextrins are known to form 
inclusion complexes with a variety of low molecular weight compounds. These 
complexes are applied in a number of fields. 
1.1 Cyclodextrins 
1.1.1 History 
The compounds nowadays called cyclodextrins were first isolated in 1891 by 
Villiers. He discovered the formation of an oligosaccharide, when starch was 
enzymatically cleaved [1]. Schardinger confirmed his result in 1904. He further 
identified the cyclic structure of the glucose oligomers and the enzyme responsible 
for the synthesis of cyclodextrins [2]. Because of his pioneering work the name 
Schardinger dextrins is often used for cyclodextrins in early literature. In the early 
literature cyclodextrins are also sometimes called cycloamyloses or cyclomalto-
oligosaccharides. The correct chemical structure of the cyclodextrins was not 
published until 1938. It was Freudenberg who characterized them as cyclic 
structures composed of α-1,4-linked glucose units (§ 1.1.2) [3]. After this 
publication it still took some years before the molecular weights of the three most 
important cyclodextrins were determined. 
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At that time the structures of these compounds were still uncertain, but in 
1942 the structures of α and β-cyclodextrin were determined by X-ray 
crystallography [4]. In 1948, the X-ray structure of γ-cyclodextrin followed and it 
was recognized that CDs can form inclusion complexes.  
The foundations of cyclodextrin chemistry were laid down in the first part of 
the 20
th
 century. Only in 1953 the first patent on cyclodextrins and their inclusion 
complexes was registered [5]. Cramer and French were the first, who recognized 
and studied possible applications by forming complexes with these compounds. 
Because of their research the way was paved for the use of cyclodextrins as 
enzyme models [6-10]. However, until 1970 only small amounts of cyclodextrins 
could be produced and high production costs prevented their wide spread usage. 
Today the cost of cyclodextrins is reduced dramatically and as a result the group of 
scientists interested in cyclodextrins is continually growing. 
1.1.2 Preparation 
Plant photosynthesis produces two main products: starch and cellulose. 
Cellulose is an insoluble, resilient structure-forming component of cells. In 
contrast, starch is essentially an energy store. It is readily solubilized and converted 
into biochemically usable forms, and it is from these that cyclodextrins are 
prepared. Starch comprises two glucose polymers, both consisting of hundreds, or 
even thousands, of D-glucopyranoside residues: amylose and ramified 
amylopectin. Amylose contains only 1,4-glycosidic linkages, while the ramified 
amylopectin also contains 1,6-bonds. Degradation of starch with a variety of 
enzymes in the presence of water gives rise to the dextrins, which result from the 
hydrolysis of glycosidic linkages. Dextrins are used in the food, textile and paper 
industries, and are consumed in the production of bread, beer etc. If dextrins are 
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degraded by the glucosyltransferase enzyme, the primary product of the chain 
splitting (a linear oligosaccharide) undergoes intramolecular cyclisation, without 
the involvement of water, to give the cyclodextrins. Individual cyclodextrins are 
isolated from the mixture by complexation with non-polar guests such as toluene 
[Figure 1.1.1], which results in dramatic decreases in solubility. Industrially 
produced cyclodextrins are generally over 99 per cent pure [11]. 
 
Figure 1.1.1 Isolation of the cyclodextrins by glucosyltransferase degradation of 
starch [11].
  
 
1.1.3 Structure 
Cyclodextrins are obtained biotechnologically in large scale by the enzymatic 
degradation of starch, by making use of a glycosyl transferase from Bacillus 
macerans (later identified as Clostridium butyricum) [12].
 
In this process cleavage 
of a turn from the starch helix, is followed by intramolecular cyclization [13]. 
Mainly three cyclic oligosaccharides are obtained. They are called α-, β-, γ- 
cyclodextrin. The cyclodextrin portion of the name comes from dextrose, an early 
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synonym for glucose. These cyclodextrins consist of six, seven and eight D-
glucose units, respectively, attached by α-1,4-linkages (Fig 1.1.2). Several other 
(minor) cyclodextrins are known, including δ-cyclodextrin and ε-cyclodextrin 
(nine and ten units, respectively), and the five-membered pre-α-cyclodextrin. 
Cyclodextrins consisting of less and more D-glucose units also exist [5], but they 
are too expensive for the development of practical applications. Other cyclic 
oligosaccharides derived from mannose and galactose are also known, but are 
much less studied. 
(A) 
                    
α-cyclodextrin                                          β-cyclodextrin 
  
γ-cyclodextrin 
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(B) 
          
Fig 1.1.2 (A) A structure of -, - and -cyclodextrin and (B) General structure of 
cyclodextrins with its traditional numbering. 
 
 
Each of the chiral glucose units is in the rigid 
4
C1-chair conformation, giving 
the macro cycle the shape of a hollow conical cylinder. The conical cylinder, 
which is frequently characterized as a doughnut or wreath-shaped truncated cone, 
is formed by the carbon skeletons of the glucose units and the glycosidic oxygen 
atoms in between those. The primary hydroxyls of the glucose units are located at 
the narrow face of the cone (primary face) and the secondary hydroxyls at the 
wide face (secondary face). A schematic side view is shown in Fig 1.1.3. Primary 
hydroxyl groups have rotational flexibility around the C
5–C6 bond to partially 
block the cavity. However, their conformation is confined to two types, gauche–
gauche and gauche–trans. In the former type, the C6–O6 bond is gauche to both 
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the C
5–O5 and C4–C5 bonds while in the other type the C6–O6 bond is gauche to the 
C
5–O5 bond and trans to the C4–C5 bond. In contrast the secondary hydroxyls are 
attached by relatively rigid chains and as a consequence they cannot rotate and are 
circularly aligned like the rim of a torus and hydrogen bonds are formed between 
an O
2–H hydroxyl group and the O3–H hydroxyl group of an adjacent glucose unit.  
The apolar C
3
 and C
5
 hydrogens and ether-like oxygens are at the inside of the 
torus-like molecules. The nonbonding electron pairs of the glycosidic oxygen 
bridges are directed towards the cavity center, producing a high electron density 
and lending to it a Lewis-base character [14]. This result in a molecule with a 
hydrophilic outside, which can dissolve in water, and an apolar cavity, which 
provides a hydrophobic matrix, described as a ‘micro heterogeneous environment’ 
[15]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.1.3 Schematic side view of cyclodextrin. 
Primary face 
Secondary face 
Hydrophobic cavity 
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1.1.4 Properties 
In general, the cyclodextrins form a relatively smooth series from α- to γ- 
cyclodextrin in terms of their physical and chemical properties, although very large 
cyclodextrins such as δ-cyclodextrin begin to deviate because they are less rigid 
than the smaller hosts and, as a consequence, exhibit much poorer guest 
complexation ability. Table 1.1.1 lists some important properties and the molecular 
dimensions of the three most common cyclodextrins [13,16].  
The primary and secondary hydroxyls on the outside of the cyclodextrins 
make cyclodextrins water-soluble. One important exception to a smooth change in 
properties, however, is the cyclodextrins’ water solubility, which is significantly 
less for the odd-numbered β-cyclodextrin than for α- and γ- cyclodextrin (as 
determined by refractometry; the measurement of the solution refractive index). 
The solubility of the odd-numbered δ-cyclodextrin is also less than for α- and γ- 
cyclodextrin, although the deviation is less marked. This relative insolubility of β-
cyclodextrin has important consequences on its applications as a solution host. 
Number of explanations has been put forward for this anomalous behavior. 
Examination of the enthalpy and entropy of hydration show that both are less 
favorable for β-cyclodextrin than for the smaller and larger analogues. This has 
been attributed to the interruption of the hydrogen-bonded structure of water by 
aggregated β-cyclodextrin. The reasoning is that the six- and eight-fold symmetries 
of the other cyclodextrins are more compatible with the solvent cage, which has an 
even number of hydrogen-bond donors and acceptors. It has also been suggested 
that the intramolecular hydrogen bonds on the secondary face of β-cyclodextrin are 
responsible for its low solubility, limiting the interactions with solvent water. The 
analogous hydrogen-bonded network is incomplete in α-CD because of strain, 
whereas γ-CD is more flexible. Indeed, methylation of the secondary hydroxyl 
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groups increases β-CD solubility in water. Cyclodextrins are insoluble in most 
organic solvents. The cavity of the cyclodextrin rings consists of a ring of C-H 
groups, a ring of glycosidic oxygen atoms and again a ring of C-H groups. This 
renders the interior of the cyclodextrin rings less polar. 
Table 1.1.1 Physical properties and molecular dimension of cyclodextrins. 
Property α-cyclodextrin β-cyclodextrin γ-cyclodextrin 
Number of glucose units 6 7 8 
Molecular weight(g.mol
-1
) 972 1135 1297 
Water solubility (g.100ml
-1
) 
25°C 
14.5 1.85 23.2 
ΔH° solution (kJ.mol-1) 32.1 34.7 32.3 
ΔS° solution (J.K-1.mol-1) 57.7 48.9 61.4 
Specific rotation [ ] 
   150.5±0.5 162.5±0.5 177.4±0.5 
Surface tension (mN/m
2
) 71 71 71 
Melting temperature range 
(°C) 
255-260 255-265 240-245 
Internal diameter (Å) 5.0 6.2 8.0 
External diameter (Å) 14.6 15.4 17.5 
Height cone (Å) 7.9 7.9 7.9 
Cavity volume (Å
3
) 174 262 427 
Cavity volume in 1 g 
cyclodextrin (cm
3
) 
0.10 0.14 0.20 
Crystalline water (wt. %) 10.2 13-15 8-18 
pKa (25ºC, by potentiometry) 12.33 12.20 12.08 
Common guests Benzene, phenol 
Napthalene, 
1-anilino-8-
napthalenesulfonate 
Anthracene, crown 
ethers,1-anilino-8-
napthalenesulfonate 
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All of the cyclodextrins crystallize from water as hydrates containing varying 
amounts of water, depending on crystallization conditions. In each case, the semi-
polar cyclodextrin cavity is filled with water molecules, which are of relatively 
high energy as a consequence of their limited interactions with the walls of the 
cyclodextrin cage. In solution, it has been suggested that a large contribution to the 
complexation of guest species is the expulsion of these high-energy water 
molecules from the cavity as part of an overall hydrophobic effect.  
Cyclodextrins are stable under alkaline conditions. They can, however, be 
cleaved by acid hydrolysis. When acid hydrolysis of cyclodextrins takes place 
glucose is produced. 
Cyclodextrins are almost nontoxic. One of the little toxicity of cyclodextrins is 
Hemolysis [17,18]. The hemolysis is a secondary event, resulting from the 
interactions of cyclodextrins with membrane components. It is reported that 
cyclodextrins at lower concentration protect the human erythrocytes against 
osmotic and heat-induced hemolysis. At higher concentrations, 37 °C, pH 7.4, in 
10 mmol.dm
-3
 isotonic phosphate buffers, however, they cause the release of 
cholesterol and phospholipids from the cell membrane resulting in cell disruption 
[17,19,20]. The activity of the cyclodextrins follows the order β-, γ- and α-
cyclodextrin, where β-cyclodextrin is the most toxic. 
Cyclodextrin complexation can give beneficial modification of guest 
molecules such as solubility enhancement, stabilization of labile guests, physical 
isolation of incompatible compounds and control of volatility and sublimation. 
Furthermore, the chemical reactivity of the guest is changed by the incorporation 
into the cavity. 
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1.2 Functionalization 
A hydrophilic exterior, formed by two rims of hydroxyl groups surrounds the 
hydrophobic molecular cavity. Various functional groups can be covalently 
attached to the hydroxyl groups [21,22]. When the hydroxyl groups are modified, 
the complexation behavior of cyclodextrins can be altered and the relatively low 
water-solubility of β-cyclodextrin can be enhanced. Selective modification of 
cyclodextrins with catalytic groups can create an enzyme like activity. For these 
purposes, several functional groups were placed on the periphery of cyclodextrins. 
Based on their availability and cavity size most of the studies have utilized α- and 
β-cyclodextrin. The binding properties of functionalized cyclodextrins are in many 
cases identical to the binding properties of the parent cyclodextrins [42,23]. 
Complexation with functionalized cyclodextrins can, however, also take place in 
organic solvents since many of the functionalized cyclodextrins are soluble in 
organic solvents. Functionalization of cyclodextrins can concern complete sets of 
hydroxyls or partial functionalization. 
As can be seen in Figure 1.1.2 (§ 1.1.3) the glucose repeating unit of a 
cyclodextrin contains three different hydroxyls. The glucose repeating unit 
contains one primary hydroxyl group at position 6. These primary hydroxyls are 
located at the narrow side of the cyclodextrin molecule. Each glucose unit also 
contains two secondary hydroxyl groups connected to C
2
 and C
3
. The primary and 
secondary hydroxyl groups have different reactivities. Also the two secondary 
hydroxyl groups have slightly different reactivities. This last difference is due to 
the fact that the hydroxyl groups attached to C
2
 are closer to the hemi-acetal then 
the hydroxyl groups attached to C
3
. This makes the hydroxyl groups attached to C
2
 
slightly more acidic and so they are slightly more reactive than the hydroxyl 
groups attached to C
3
.  
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There are several reasons for the functionalization of a complete set of 
hydroxyls. The reason is often the enhancement of the solubility in water or in 
organic solvents, the protection of hydroxyl groups so other hydroxyl groups can 
react, or the activation of a set of hydroxyl groups by the introduction of good 
leaving groups for further fictionalization of that set. Acylation, alkylation, or 
silylation of complete sets of hydroxyls can enhance the solubility of cyclodextrins 
in common organic solvents. 
Besides the functionalization of complete sets of hydroxyl groups it is also 
possible, to selectively functionalize one hydroxyl group of a cyclodextrin 
molecule. The selective monofunctionalization of cyclodextrins has been 
extensively studied for the primary hydroxyl face and less well for the secondary 
hydroxyl face. The reason is that selective functionalization of the more 
nucleophilic primary hydroxyls over the more acidic secondary hydroxyls is easier 
than the reverse [24-28].
 
Among the first cyclodextrin derivatives that appeared in the literature, were 
acylated cyclodextrins. Since then, many acylated cyclodextrins with different 
functionalization have been reported [29-34]. In many case these compounds were 
prepared for purification purposes and the acyl groups were removed after 
purification of the compound. Alkylation of the hydroxyls of cyclodextrins first 
takes place at the more nucleophilic C
6
 and the more acidic C
2
 hydroxyl groups 
[35]. Because the C
3
 hydroxyl groups point to the center of the cavity when the C
2
 
hydroxyl groups are functionalized, they tend to react very slowly in the alkylation 
reaction. One of the most common alkylation is methylation. Methylation can be 
used to enhance the solubility of cyclodextrins in water. Methylation of free 
cyclodextrins can be performed for example with methyl iodide [36,37]. 
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Protection of the nucleophilic primary hydroxyls by silylation leads to 
cyclodextrin derivatives, which are soluble in organic solvents and relatively easy 
to obtain as pure compounds. Because the formed silyl ethers are stable under most 
reaction conditions, the silylated cyclodextrins can be used as intermediates for 
further functionalization. 
1.3 Cyclodextrin-containing inclusion compounds 
1.3.1 Formation 
Because of the relatively apolar cavity in comparison to the polar exterior, 
cyclodextrins can form inclusion compounds with hydrophobic guest molecules in 
aqueous solutions predominantly due to hydrophobic effect [38-40]. However, the 
possibility to form hydrophobic effect represents only one of the requirements.  
When a complex is formed the surface of the hydrophobic interior of the 
cyclodextrin and the hydrophobic exterior of the guest molecule exposed to 
hydrophilic solvent is decreased. It must be emphasized that the phenomenon of 
cyclodextrin inclusion compound formation is a complicated process and in reality 
there are many factors that play a role [41]. This is illustrated by the fact that not 
only apolar compounds can be included but also acids, amides, small ions and even 
rare gases [42,43]. 
The driving force for guest inclusion involves a number of contributions, the 
importance of which is still a matter of some debate. Chiefly the factors of 
importance are: 
 Steric fit; 
 Release of high-energy water; 
 Hydrophobic effects; 
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 Van der Waals interactions; 
 Dipole–dipole interactions; 
 Charge-transfer interactions; 
 Electrostatic interactions;  
 Hydrogen bonding. 
Release of high-energy water and the hydrophobic effect, comprise two 
energetic components: enthalpic gain as high-energy solvent molecules rejoin the 
bulk and, entropic gain as two holes in the solvent (host and guest) are reduced to 
one (complex). The classical hydrophobic effect involves a clearly negative ΔS°, 
but this is not always the case for cyclodextrin complexes because the cavity is not 
really non-polar. It has a variety of functionalities and is better described as ‘semi-
polar’. Another requirement is that the guest molecule must be able to fit inside the 
cavity of the cyclodextrin.  
In addition to size fit and solvation effects, solid and solution complexes are 
often stabilized by additional enthalpically favorable interactions, such as 
hydrogen bonds between the guest and the primary or secondary cyclodextrin 
hydroxyl groups and dipolar interactions.  
Table 1.1.1 (§ 1.1.4) shows that, in general, the size of guest that may be 
accommodated increases as the size of the cyclodextrin becomes larger, although 
there is some flexibility in the host structures and size fit is not a rigid criterion. 
Small molecules normally form 1:1 inclusion compounds. In such an inclusion 
compound, one cyclodextrin ring includes one guest. It is also possible, that the 
guest is only partly included by one cyclodextrin. This is the case when molecules 
larger than the cavity have to be included. When the molecule is even larger also 
2:1 and other types of inclusion compounds can be formed. The geometric shape of 
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guest molecule also plays an important role in the type of complexation. Flat 
molecules, for example, sometimes lead to 3:2 complex type.  As for the relatively 
long chain molecules, this leads to complex with higher orders.  
Complexes can be formed either in solution or in the crystalline state and 
water is typically the solvent of choice. Inclusion complexation can be 
accomplished in a co-solvent system and in the presence of any non-aqueous 
solvent. The inclusion complex compound formation by cyclodextrins is 
historically carried out in water. However, also inclusion compound formation in 
dimethylformamide is described [44]. It is also possible to form inclusion 
compounds in the crystalline state [45]. Thus, the stability and the stoichiometry of 
formed inclusion complexes depend on the structure of the guest compound, on the 
kind of CD, and the solvent and additives applied. 
1.3.2 Application of inclusion compounds  
As discussed in § 1.1.1, until 1970 cyclodextrins were produced at small scale. 
Recent biotechnological advancements have resulted in dramatic improvements in 
cyclodextrin production, which has lowered their production costs. Industrial 
production of the most important member of the cyclodextrin family, β-
cyclodextrin, is about 1500 tons per year, and its price is just a few US dollars per 
kilogram. This has led to a wider commercial availability of purified cyclodextrins 
and cyclodextrin derivatives. The beneficial modification of guest molecular 
properties after the formation of an inclusion compound leads to a large number of 
applications related to cosmetics and pharmaceutical sectors, generally as slow-
release and compound-delivery agents, food technology, textiles, stationary phase 
in HPLC column,  chemical sensors, nanoparticles, analytical chemistry, chemical 
synthesis and catalysis [13,18,46-63] As already mentioned, cyclodextrins are 
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practically nontoxic and as a result they are allowed in pharmaceuticals and foods. 
Stabilization of labile compounds and long-term protection of color, odor and 
flavor represent some of the possible applications in these areas [13,17,18]. 
1.3.3 Detection of inclusion compounds  
Inclusion compounds can be detected by a variety of spectrometric methods. 
The most direct evidence for the inclusion of a guest into the cyclodextrin cavity in 
solution can be obtained by proton nuclear magnetic resonance spectroscopy (
1
H-
NMR). The chemical shifts for the protons attached to C
3
 and C
5
 move 
significantly upfield in the 
1
H-NMR spectrum in the presence of a guest. The 
magnitude of the shifts increases slightly on going from α-cyclodextrin to β-
cyclodextrin and dramatically on going to γ-cyclodextrin. Additionally the shift for 
the C
5
 protons is larger than for the C
3
 protons due to the rigid conical shape of the 
cyclodextrins. On the other hand the C
1
, C
2
 and C
4
 protons located at the exterior 
of the cavity show only a marginal upfield shift [6].
 
Usually, the 
1
H-NMR signals of the included guest molecules shift downfield 
compared to the free molecules [64,65].
 
In the 
1
H-NMR spectra of inclusion 
compounds the signals of the guests are significantly broadened.  
In addition to the magnetic properties of the protons, other physicochemical 
properties of the guest molecules are also varied upon inclusion complexation. 
Among others the electronic absorption, fluorescence, phosphorescence and optical 
rotation properties for the guests are more or less varied as a result of incorporation 
into a cyclodextrin cavity [66-82]. 
The structure of the inclusion compound can be detected with X-ray 
diffraction [83-88]. Especially X-ray analysis of cyclodextrin inclusion compounds 
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containing organometallics as guests has been used to investigate the structural and 
to some extent the dynamic host−guest interactions [83]. When the temperature is 
decreased, the disorder attributed to the absence of strong host−guest interactions, 
is reduced. This allows a more precise determination of the molecular parameters 
of the included species, and analysis of the influence of the geometry on the 
molecular conformation and electron density. 
Thermal analysis has also been used in the study of inclusion compounds 
[89,90]. In some cases no melting peaks of the guests are observed after the 
formation of complexes. The thermal decomposition of inclusion compounds was 
studied only scarcely [91,92]. It was observed that the decomposition of the 
complexed guest occurs above the decomposition temperature of the uncomplexed 
molecule. Although scarcely studied this thermal decomposition behavior of guests 
included inside cyclodextrins and the increase of the stability of the guest when 
included, is used in a variety of applications. 
1.4 Crystallographic Study of Cyclodextrins 
From the discovery of cyclodextrins at the end of 19th century, it was more 
than 70 years before X-ray analysis explored the three-dimensional structure of 
cyclodextrins. In the early stage of cyclodextrin study, the cyclic structure of 
cyclodextrins was expected from various chemical analyses; however, without 
knowledge of the three-dimensional structure, it was difficult to fully understand 
the unique characteristics of cyclodextrins capable of forming inclusion complexes 
with a variety of guest compounds. X-ray structures provided the direct evidence 
of the inclusion of the guest molecule in the cyclodextrin cavity. 
The development of the structural study of cyclodextrins in the last century 
has been summarized in several reviews [12,13,93-97]. In 1942, the 
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crystallographic method was first applied to cyclodextrins to determine molecular 
weight [4]. James et al. proposed a packing structure for several crystalline 
complexes of α-cyclodextrin with small guest molecules in 1959 [98]. Preliminary 
crystallographic data of β-cyclodextrin complexes with benzene derivatives were 
reported in 1968 [99]. The crystal structure first solved by X-ray analysis in 1965 
was that of the α-cyclodextrin complex with potassium acetate [100]. Structures of 
two other well-known cyclodextrins, β-cyclodextrin and γ-cyclodextrin were 
determined in 1976 and 1980, respectively [101-103]. An up-to-date list of crystal 
structures determined by x-ray and/or neutron diffraction is collected in the 
Cambridge Crystallographic Database (http://www.ccdc.cam.ac.uk/). 
Cyclodextrins consisting of 6 to 31 glucose units have been separated from a 
reaction product of cyclodextrin glycosyltransferase. Three dimensional structures 
of cyclodextrins have been determined for α-, β-, γ-, δ-, ε-, and ι-cyclodextrins 
which consist of 6, 7, 8, 9, 10, and 14 glucose units, respectively, by X-ray and 
neutron diffraction analyses [104-113]. The enzymatic degradation of starch by 
potato D-enzyme, a kind of α-amylase, produces cyclodextrins having more than 
17 glucose units. Among these large cyclodextrins, the crystal structure of 
cyclomalatohexaicosaose consisting of 26 glucose units has been determined 
[114].
 
Cyclodextrins consisting of 6–9 glucose units exhibit a doughnut-shaped 
structure [104-110]. These cyclodextrins are approximately in the shape of a 
truncated polygonal cone. The macrocycle of cyclodextrins is distorted from its 
ideal structure with n-fold symmetry to relieve the steric hindrance between 
glucose units and distortion of the glycosidic linkage. Upon complex formation, 
cyclodextrins change their macrocyclic structure and adjust the structure of the 
cavity to accommodate the guest molecule. The shape of the cyclodextrin ring is 
- 31 - 
 
well characterized by using a polygon consisting of glycosidic O
4n
 atoms which are 
nearly coplanar Table 1.4.1 The radius of the polygon, that is the average of the 
distance from the center of the polygon to each O
4n
 atom, is a good measure to 
estimate the size of the macrocycle. The radius varies in the range from 4.2Å in α-
cyclodextrin to 6.4Å in δ-cyclodextrin. The α-1,4 linkage is responsible for the 
conformational flexibility of the macrocycle. The pyranose ring is almost 
perpendicular to the O
4n
 plane but the average over all the glucose units indicates 
that the pyranose ring is generally tilted with its primary hydroxyl side towards the 
inside of the macrocyclic ring. The rotational movement of glucose units around 
the glycosidic linkage distorts the macrocyclic ring by increasing the degree of 
inclination of each glucose unit against the plane through the glycosidic O
4n
 atoms. 
Table 1.4.1 Geometrical data of cyclodextrin [115].
 
 α (6) β (7) γ (8) δ (9) ε (10) ι (14) 
Radius of the O
4
 polygon (Å) 4.2(1) 5.0(2) 5.9(1) 6.4(7) 6.9(4) 8.4(10) 
O
4n…O4(n+1) distance (Å) 4.2(1) 4.3(1) 4.5(1) 4.5(1) 4.5(1) 4.5(1) 
O
2n…O3(n+1) distance(Å) 3.0(1) 2.9(1) 2.8(1) 2.9(2) 3.2(2) 2.9(2) 
Planarity of the O
4n
 polygon 
(Å)
(a) 0.10 0.16 0.11 0.80 - - 
Glycosidic O
4
 angle:  
O
4(n-1)…O4n…O4(n+1) 
119(1) 118(1) 117(1) 116(2) 117(1) 118(1) 
Tilt angle (°)
(b) 13.0(10) 14.0(10) 19.0(9) 25.0(20) - - 
(a)
 Root-mean-square deviation of O
4n
 atoms from their least-squares plane. 
(b)
 Average angle between the O
4n
 plane and the plane through C
1n
, C
4n
, O
4n
, O
4(n+1)
and of each 
glucose unit. 
 
The tilt of each glucose unit is evaluated by the ‘‘tilt-angle’’, which is defined 
as the angle measured between the plane of the O
4n
 polygon and the plane through 
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C
1n
, C
4n
, O
4n
, and O
4(n+1)
 of each glucose unit. The tilt angle is largely in the range 
from 10° to 20°. Such flexibility of glucose units is still restrained by 
intramolecular hydrogen bonds of secondary hydroxyl groups formed between 
adjacent glucose units. When these hydrogen bonds are disrupted, glucose units 
gain high flexibility around the glycosidic linkage as is seen in the structures of 
permethylated cyclodextrins and peracetylated cyclodextrins [116].   
The water distribution in various forms of the crystalline hydrates is 
summarized in Table 1.4.2 Note that the solid-state cavity volume is limited for 
larger cyclodextrins by inclusion of glucose residues from adjacent hosts. Each 
cyclodextrin crystallizes in a variety of forms (denoted by Roman numerals for 
well-characterized cases). In general, the structures of the cyclodextrin hosts 
themselves do not vary greatly from one form to another, and the differences lie in 
the distribution of the water molecules. α-Cyclodextrin crystallizes from water in 
three forms, hexahydrate (Form I and Form II) and 7.57 hydrate (Form III) (CSD-
code: BANXUJ) [117]. The flexible macrocyclic ring is demonstrated by the 
distinct conformational changes of α-cyclodextrin observed among these crystals. 
α-Cyclodextrin  adopts an elliptically distorted, irregular shape in forms I and III, 
with two glucose units rotated about their glycosidic linkage to present the primary 
hydroxyl side inwards towards the cavity, making the cavity volume smaller. The 
form II hydrate is more regular. The structure of α-cyclodextrin hydrate form I 
(CSD-code: CHXAMH) is shown in Figure 1.4.1 [111]. 
β-cyclodextrin crystallizes in two forms, dodecahydrate (I) [112] (CSD-code: 
BCDEXD10) and undecahydrate (II) [113] (CSD-Code: BUVSEQ). Both forms of 
the β-cyclodextrin have similar host geometries, which are much more regular than 
α- cyclodextrin, but the change occurs in the arrangement of water molecules in the 
cavity with the occupancies of some of the disordered water sites being higher in  
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Table 1.4.2 Solid-state cyclodextrin hydrates. 
 α β γ δ 
Number of water 
molecules (form) 
6 (I) 
6 (II) 
7.57 (III) 
12 (I) 
11 (II) 
19 
14.1 
15.7 
13.75 
Number of water 
molecules in cavity (form) 
2 (I) 
1 (II) 
2.57 (III) 
7.3 (I) 
6.3 (II) 
 
7.1 to 14.1 
Two 
glucose 
units 
occupy 
cavity 
 
Two glucose 
units occupy 
cavity; water 
distributed 
in open 
space on 
primary face 
 
 
 
Figure 1.4.1 Two views of the X-ray crystal structure of form I of α-CD hydrate. 
form I. γ-Cyclodextrin  has  the  most  symmetrical  structure  among  the  four 
cyclodextrins. The structure of γ-cyclodextrin closely resembles that of β- 
cyclodextrin, and again there is complex disorder of the water molecules [114] 
(CSD-code: CIWMIE10). Both hosts exhibit a regular array of intramolecular 
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hydrogen bonds on the primary face with O … O contacts in the range 2.70–3.00 
Å. In contrast, δ-cyclodextrin is elliptically distorted and the ring deviates 
considerably from the planar structure, the structure is distorted into a boat-like 
shape, giving it a shallower cavity [115] (CSD-code: SIYKOA). In cyclodextrins 
consisting of more than nine glucose units, the macrocyclic ring is no longer 
doughnut shaped [Figure 1.4.2]. Because of the strain imposed on the glycosidic 
linkage, the molecule cannot retain the round structure; instead, the elliptical ring 
is bent into a shape like a saddle [116-118] in cyclodextrins composed of 10 and 14 
glucose units, ε- and ι-cyclodextrin, respectively (CSD-Code: NOBBUB and 
NOBBUB).  
The structure of a cyclodextrin consisting of 26 glucose units, the largest one 
whose structure has been determined by X-ray analysis, is not circular but consists 
of two left-handed amylose-like helixes [119] [Figure 1.4.3]. The molecule has 
two- fold symmetry and the two asymmetric parts are connected by glucose units 
with the trans arrangement.  Inclusion of the guest molecule induces a structural 
change in the cyclodextrin. As shown in the structure of δ-cyclodextrin and its 
complex [121], complex formation changes the elliptically distorted macrocyclic 
ring to a round structure with pseudo nine-fold symmetry [110,121]. 
In crystals of cyclodextrin complexes, the crystal packing is generally 
governed by the arrangement of cyclodextrin molecules because they dominate the 
intermolecular contact to form the crystal lattice. However, the packing mode is 
not unique for a particular cyclodextrin but varies according to the guest molecule. 
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ε-cyclodextrin                                                 ι-cyclodextrin 
Figure 1.4.2 Side and top views of the structures of ε- and ι-cyclodextrin consisting 
of 10 and 14 glucose units, respectively [120].
 
 
Figure 1.4.3 Side and top views of the structures of cyclomalatohexaicosaose 
consisting of 26 glucose units, the molecules consist of two left-handed helical 
structures related by a two-fold symmetry [119].
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There are three packing types: cage type, channel type, and layer type, which 
are widely observed. The possible packing modes are illustrated in Figure 1.4.4. 
Guest molecules determine the selection of one of these packing modes, which 
provides a suitable cavity into which they can be stably accommodated. 
The cage-type packing structure is frequently observed for relatively small 
guest molecules which can be enclosed in the host cavity. Cyclodextrin molecules 
are arranged in a herring-bone fashion and both ends of the host cavity are closed 
by adjacent molecules to create an isolated ‘‘cage’’ [Figure 1.4.4-A]. The channel-
type structure is formed by linear stacking of cyclodextrin rings. This column-like 
structure has an infinite cylindrical channel that can accommodate a long molecule 
such as an alkyl chain or a linear polymer. There are two types of cyclodextrin 
arrangement, called ‘‘head-to-head’’ and ‘‘head-to-tail’’. The first structure is 
formed by the linear arrangement of head-to-head cyclodextrin dimers. In the 
dimer unit, the secondary hydroxyl side of two molecules is facing each other and 
connected by hydrogen bonds to create a barrel-like cavity [Figure 1.4.4-B]. In the 
head-to-tail packing structure, cyclodextrin rings are linearly stacked and the 
primary hydroxyl side faces the secondary hydroxyl side of the next molecule by 
hydrogen bonds [Figure 1.4.4-C]. The layer-type packing structure has been 
sometimes observed when the guest molecule is so large that a part of the molecule 
cannot be accommodated within the cyclodextrin cavity. Cyclodextrin rings are 
arranged in a plane to make a molecular layer and two adjacent layers are shifted 
with respect to each other by half a molecule, showing a brick-work pattern 
[Figure 1.4.4-D]. Both ends of the cavity are open to an intermolecular space of the 
adjacent layers. A part of the guest molecule not included in the host cavity 
protrudes into the intermolecular space and is in contact with host molecules of the 
adjacent layer. 
- 37 - 
 
                
(A)                                                             (B)                                  
                   
     (C)                                                         (D)                                  
Figure 1.4.4 Schematic drawing of crystal packing: cage-type observed in the β-
cyclodextrin complex with hexamethylenetetramine (A), head-to-head channel-
type observed in the α-cyclodextrin complex with iodine-iodide (B), head-to-tail 
channel-type observed in sodium diclofenac (C) and layer-type observed in the α-
cyclodextrin complex with p-nitrophenol (D). 
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1.5 Aim and outline of this thesis 
The main objective of this thesis was to design new crystal systems 
containing cyclodextrins in combination with:  
1. Para aminobenzoic acid as a drug model to study the effect of complexation 
phenomena on the solubility of drugs and characterize their structure and mode 
of interaction by combination a theoretical and experimental approach. Despite 
of the existence of previous studies on the interaction between pABA and α-
CD, but, to our knowledge, there are no crystal structure nor data about the 
effect of α-CD on the solubility of pABA. We provide here a comprehensive 
study from the solution to the crystalline state.  
2. Potassium hydroxide to prepare cyclodextrin Metal-Organic Frameworks (CD-
MOFs) formed by coordinating the cyclodextrins to potassium cation. 
Consequently taking the advantages of this interaction between cyclodextrin 
and alkali metal cation to favor formation of inclusion complexes as CD-MOFs 
drug carrier.  In fact there are some crystal structures show metal cations 
coordinated by CDs, we present here an original strategy for using MOFs, 
based on interaction of potassium cation with CD, as a drug carrier.  
3. Aegelinol, a natural product, for analytical purposes to determine the absolute 
configuration of this compound by formation of an inclusion complex with a 
host of known chirality (cyclodextrins consists of several optically active D-
glucose units). This should allow direct determination of the absolute 
configuration of the guest (aegelinol). Many crystal structures of inclusion 
complexes of cyclodextrins with chiral molecules are already known, but, to 
our knowledge, no one used cyclodextrins as a reference to determine the 
absolute configuration by X-ray diffraction technique. 
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Single crystal X-ray diffraction technique was mainly used in this work to 
determine the crystal structures of the different treated systems. With regard that 
the preparation of suitable crystals has been performed by two different methods: 
crystallization by slow evaporation and crystallization by slow vapor diffusion. 
The UV spectral technique was used to obtain estimates of Kc for the α-CD-
pABA system. The method involves the measurement of absorbance changes of 
pABA in the absence and presence of α-CD. The UV spectral technique has been 
also used to estimate the solubility of pABA in absence and presence of α-CD by 
relying on the Beer-Lambert equation.  
A theoretical investigation, by using Ab-initio energy minimization and 
semiempirical PM6 calculation has been also carried out on different pABA, α-CD 
and α-CD-pABA systems in order to evaluate relative stability of other stable 
complexes involving different forms of pABA.  
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Chapter 2 
Crystallographic, UV spectroscopic and computational 
studies of the inclusion complex of α-cyclodextrin with p-
aminobenzoic acid. 
This work has been published in part in:  Supramolecular Chemistry, Vol. 24, No. 5, May 2012, 312–324 
(A reprint of this work is available at the end of this thesis) 
 
 
Abstract 
Crystal structure of the cyclomaltohexaose (α-Cyclodextrin, α-CD) inclusion 
complex with p-Aminobenzoic acid (pABA) has been determined by X-ray 
diffraction. The host:guest stoichiometry is 1:1. The pABA molecule is included in 
the cavity with its axis coincident with the axis of α-Cyclodextrin; the benzoic 
group is inserted in the cavity, while the amino group sticks out from the cavity. 
Four water molecules are located near the cavity rims and in interstices between 
molecules of α-CD participating to a dense network of intermolecular hydrogen 
bonds. UV-visible spectroscopy was applied to estimate the stability constant (Kc) 
at different temperatures on the basis of the Benesi-Hildebrand equation. This 
allowed calculation of complexation ΔHc and ΔSc on basis of the Van’t Hoff 
equation. The results are in good agreement with the values obtained by other 
methods in literature. Phase solubility profiles indicate that the solubility of pABA 
is significantly increased in the presence of α-CD, at different pH values, and it 
was classified as AL- type, indicating a 1:1 stoichiometric inclusion complex in 
solution. A theoretical investigation has also been carried out on the α-CD-pABA 
systems in order to search for other stable complexes. PM6 semiempirical 
calculations were performed to investigate equilibrium geometries of inclusion 
complexes formed between α-CD and neutral, anionic, cationic and zwitterionic 
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forms of pABA. Two possible orientations were considered (A, with the carboxylic 
end inside the cavity and B, with the amino group inside the cavity). Preference 
between A or B orientations of each α-CD-pABA form results from different H-
bond interaction patterns.  
2.1 Introduction 
In pharmaceutical practice poor water solubility of drugs is a well-known 
problem. At present about 40% of the drugs in the development pipelines and up to 
60% of the compounds coming directly from synthesis are poorly soluble [1]. To 
act on target receptors, drugs must generally be dissolved in the physiological fluid 
and thereafter absorbed through entrance ports. Various methods have been used to 
increase the dissolution rate including micronization, modification of the 
physicochemical properties of the drug, addition of water-soluble polymers or 
complex formation with Cyclodextrins (CDs). 
4-Aminobenzoic acid (pABA) is an organic compound with the formula 
H2NC6H4CO2H. pABA is a white grey crystalline substance that is only slightly 
soluble in water. It consists of a benzene ring substituted with an amino group and 
a carboxyl group. 
 
 
 
- 50 - 
 
In industry, pABA is prepared mainly by two routes:  
1)  Reduction of 4-nitrobenzoic acid and the Hoffman degradation of the 
monoamide derived from terephthalic acid.[2]  
2)  Food sources of pABA include liver, brewer's yeast (and unfiltered beer), 
kidney, molasses, mushrooms, and whole grains.[3] 
pABA is an intermediate in the bacterial synthesis of folate. pABA has been 
referred to as Vitamin B10.[4] Some bacteria in the human intestinal tract such as E. 
coli generate pABA from chorismate.[5-6] Humans lack the enzymes to convert 
pABA to folate, and therefore require folate from dietary sources such as green 
leafy vegetables. Although some intestinal bacteria can synthesize folate from 
pABA[7] and some E. coli can synthesize folate,[8] this requires six enzymatic 
activities in folate synthesis which are not all done in the same bacteria Fig 2.1.1. 
In humans pABA is considered nonessential and is not recognized as a vitamin [9].  
Sulfonamide drugs are structurally similar to pABA, and their antibacterial 
activity is due to their ability to interfere with the conversion of pABA to folate by 
the enzyme dihydropteroate synthetase. Thus, bacterial growth is limited through 
folate deficiency without effect on human cells Fig 2.1.1 [10].
  
The potassium salt of pABA is used as a drug against fibrotic skin disorders, 
such as Peyronie's disease, under the trade name Potaba [11]. pABA is also 
occasionally used in pill form by sufferers of irritable bowel syndrome to treat its 
associated gastrointestinal symptoms, and in nutritional epidemiological studies to 
assess the completeness of 24-hour urine collection for the determination of 
urinary sodium, potassium, or nitrogen levels. Despite the lack of any recognized 
syndromes of pABA deficiency in humans, many claims of benefit are made by 
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 Fig 2.1.1 Synthesize folate from pABA by bacteria. 
commercial suppliers of pABA as a nutritional supplement. Benefit is claimed for 
fatigue, irritability, depression, weeping eczema (moist eczema), scleroderma 
(premature hardening of skin), patchy pigment loss in skin (vitiligo), and 
premature grey hair.[12] It is also sometimes claimed that oral supplements of 
pABA can make the skin less sensitive to sun damage. 
pABA mainly finds use in the biomedical sector. Other uses include its 
conversion to specialty azo dyes and crosslinking agents. In the past, pABA was 
widely used in sunscreens as a UV filter. It is a UVB absorber, meaning that it can 
absorb wavelengths between 290-320 nm.[13] Patented in 1943, pABA was one of 
the first active ingredients to be used in sunscreen.[14] The first in vivo studies on 
mice showed that pABA reduced UV damage. In addition, pABA was shown to 
protect against skin tumors in rodents. [15] Animal and in vitro studies in the early 
1980s suggested pABA might increase the risk of cellular UV damage.[16] On the 
basis of these studies as well as problems with allergies and clothing discoloration, 
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pABA fell out of favor as a sunscreen. However, water-insoluble pABA 
derivatives such as padimate O are currently used in some products. 
pABA is largely nontoxic; the median lethal dose of pABA in dogs (oral) is 2 
g/kg [2]. Allergic reactions to pABA can occur. pABA is formed in the metabolism 
of certain ester local anesthetics, and many allergic reactions to local anesthetics 
are the result of reactions to pABA [17]. 
p-Aminobenzoic acid (pABA) crystallizes in two different polymorphic 
forms: the α-polymorph (The unit-cell dimensions are:  a = 18.551, b = 3.860, c = 
18.642 Å, β = 93.56°; Z = 8 and space group is P21/n [CSD-Code: AMBNAC01], 
which is the commercially available form and appears as long, fibrous needles, and 
the β-polymorph (The unit-cell dimensions are:  a = 6.275, b = 8.550, c = 12.800 
Å, and β = 108.30°; Z =4 and space group P21/c[CSD-Code: AMBNAC04] [18-
22], which appears in the form of prisms [Fig 2.1.2 and  Fig 2.1.3].  
 
Fig 2.1.2 The prismatic crystals are the β-modification, and needles are the α-
modification of pABA. [21] 
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The system is enantiotropic* with a transition temperature of 25 °C, below which 
the β-form is the stable polymorph. At the transition temperature, the enthalpy of 
the β-form is about 5.5 kJ/mol lower than that of the α-form, and the entropy is  
 
                   β-modificaton                                           α-modificaton                       
Fig 2.1.3 Crystal structure of different polymorphic forms of pABA [21]. 
 
about 19 J/mol lower. The β-form crystals usually need hours or days to grow at 
the very slow cooling method, while needles usually appear easily in seconds by 
slow evaporation or slow cooling methods. By careful control of supersaturation 
and temperature, cooling crystallization can be performed to produce the pure β-
form in water and in ethyl acetate. The α-form structure is governed by carboxylic 
acid dimers [Fig 2.1.3] and is kinetically favored since it is believed that the 
corresponding dimers easily form in the solution, especially in less polar solvents. 
The solubilities of the two forms are quite close [Table 2.1.1].[21] 
 
 
*In terms of thermodynamics, there are two types of polymorphism. For a monotropic system, a plot of 
the free energy of the various polymorphs against temperature do not cross before all polymorphs melt, in 
other words, any transition from one polymorph to another will be irreversible. For an enantiotropic 
system, a plot of the free energy against temperature shows a crossing point before the various melting 
points, and it may be possible to convert reversibly between the two polymorphs on heating and cooling. 
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Table 2.1.1 Solubility of p-Aminobenzoic Acid, g/kg Solvent.[21]  
 
SD: standard deviation  
Crystal structures of α-CD complexes with various guests have been reported 
[23], suggesting that a para-substituted phenol is a suitable guest for α-CD. Crystal 
structures of α-CD complexes with p-Hydroxybenzoic acid (p-COOHC6H4OH), p-
Nitrophenol (p-NO2C6H4-OH), p-Iodophenol, and p-Fluorophenol have been 
successfully determined [24-26]. A number of studies were performed on the 
inclusion complex of pABA with α-CD in solution using calorimetry, circular 
dichroism, florescence, 
1
H NMR, fluorimetry and theoretical methods [27-35]. 
Complex formation of α- and β-cyclodextrins with pABA in water at 298.15 K was 
studied by 
1
H NMR by Irina et al [33]. The formation of 1:1 inclusion complexes 
in the two systems was observed. The complex formation was shown by the 
changes in the chemical shifts of both host and guest. The changes were clearly 
observed in the chemical shifts of signals related to H(3) and H(5) protons that are 
located inside the macrocyclic cavity at the wider and narrow rims of 
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Cyclodextrins, respectively, and they are most sensitive to the inclusion process 
[Fig 2.1.4].  
 
(1)                                                                    
(2)   
Fig 2.1.4 
1) Partial 1H NMR spectra (200 MHz, 298.15 K) of 5 mM α-CD alone (a) and in 
the presence of 5 mM pABA (b). [33] 
2) Partial 1H NMR spectra (200 MHz, 298.15 K) of 5 mM β-CD alone (a) and in 
the presence of 5 mM pABA (b). [33] 
 
Crystal structure of β-cyclodextrin complex with pABA was determined by 
single-crystal X-ray diffraction. The space group of the β-cyclodextrin–pABA 
complex is P21 with cell parameters a = 15.2196(10), b = 10.2279(7), c = 
20.9321(14) Å, β = 110.9270(10)° and Z = 2 [CSD-Code: VOJLIQ] [35]. With a 
host:guest stoichiometry of 1:1. 
To the best of our knowledge, no crystal structure of inclusion complex of 
pABA and α-CD has been reported so far. In the present study the crystal structure 
of the α-CD and pABA inclusion complex has been determined, UV-visible 
spectroscopic has been applied to determine the stability constant (Kc) and 
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thermodynamic parameters (ΔHc and ΔSc) of pABA complexation with α-CD, and 
a theoretical investigation has been carried out on different α-CD-pABA systems 
in order to evaluate relative stability of other stable complexes involving different 
forms of pABA.  
2.2 Experimental  
2.2.1 Materials 
pABA (analytical reagent grade) and -CD were purchased from Sigma-
Aldrich, GmbH P.O. 1120, 89552 Steinheim, Germany. Other reagents were of 
analytical reagent grade and doubly distilled water was used throughout. Buffer 
solutions at pH=1.5, 3.5, and 6.0 were prepared by using phosphoric acid (85%) 
and its mono and disodium salts. 
  
2.2.2 X-ray diffraction analysis 
2.2.2.1 Crystallization  
Crystals of α-CD in complex with pABA were prepared by dissolving α-CD 
(0.1mmol) in water (2.5 mL) at 65°C and pABA (0.1mmol) in ethanol (2.5 mL) at 
65°C. Both solutions were mixed and stirred at 65°C for 6 hours. Then the mixture 
was stored at room temperature. Colorless crystals suitable for X-ray data 
collection were obtained by slow evaporation after one week. 
2.2.2.2 X-ray diffraction experiment 
X-ray diffraction experiment was carried out on an Oxford Gemini R Ultra 
using Mo Kα radiation (λ=0.71073Å) operating at 50 kV, 30 mA. A single crystal 
of the complex of α-CD-pABA was mounted on the head of the 4-circle kappa 
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goniometer. A total of 17075 unique reflections were measured in the θ-range 
3.28-32.57°. Data reduction was carried out with the CrysAlisPro program [36]. 
Crystal data collection and refinement details are listed in Table 2.2.1. The 
structure belongs to the orthorhombic P212121 space group with unit cell 
dimensions a =13.4823(3), b =15.5091(2), c =24.8256(4) Å. 
2.2.2.3 Structure solution and refinement.  
The structure of the complex was determined by direct methods and refined 
using full-matrix least-squares based on F
2
 with the program SHELX [37], based 
on 775 parameters and 2 restraints. The refinement converged to   R1 = 0.0554 for   
9586 Fo > 4sig(Fo) and 0.1022 for all 17075 data. Four water molecules (two 
ordered and two disordered over two positions) were located in difference Fourier 
maps. All non-hydrogen atoms were anisotropically refined. Secondary hydroxyl 
groups were refined with two alternate conformations. Hydrogen atoms were 
calculated at ideal positions and refined using a riding model except those attached 
to some hydroxyl groups and on the two ordered water molecules that were located 
in difference Fourier maps. 
2.2.2.4 Statistical search in the Cambridge Structure Database.  
A statistical survey of the Cambridge Structural Database was performed 
searching for aromatic rings substituted by a carboxylic (-COOH), or carboxylate 
(-COO
-
) group, and in its para position an amino (-NH2), or ammonium (-NH3
+
) 
group. The statistical procedures used the VISTA software associated with 
CSD/2011 package [23]. In this study we focused on the C–O and Car–C bound 
lengths in carboxylic or carboxylate groups and on the Car–N bond length in amino 
or ammonium groups. The results were compared with the values in the crystal 
structure to establish the protonation state of pABA in the complex. 
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Table 2.2.1 Crystallographic data. 
Chemical formula 
C36H60O36.C7H7NO2.4H2O 
Formula weight (g.mol
-1
) 1120.00 
Temperature (K) 293(2)  
Wavelength (Å) 0.71073   
Crystal system orthorhombic 
Space group P212121 
a (Å) 13.4823(3) 
b (Å) 15.5091(2) 
c (Å) 24.8256(4) 
α (°) 90.000 
β (°) 90.000 
γ (°) 90.000 
Volume (Å
3
) 5190.99(16) 
Z 4 
Crystal size (mm)    0.50×0.30×0.18 
Calculated density  (g.cm
-3
) 1.498 
F(0 0 0) 2468 
Theta range for data collection (°) 3.28 - 32.57 
Limiting indices -20 ≤ h ≤17, -13 ≤ k ≤23, -37 ≤ l ≤33 
Reflections collected/unique 37378 / 17075 
R (int) 0.0293 
Data / restraints / parameters 17075 / 2 / 778 
Goodness-of-fit (S) on F
2
 0.9 
Refinement method Full-matrix least-squares on F
2
 
Final R indice (for 9586 with F0
2
 >4σ(F0
2
)) 0.0553 
Final R indices (all 17075data) 0.1021 
Largest difference peak and hole (e/Å
3
) 0.37 And   -0.50 
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2.2.3 UV-visible absorption spectroscopy 
UV-visible absorption spectra were recorded with a UVIKON XS 
spectrophotometer (Bio-TEK, Milano, Italy) at 1, 5, 10, 15, 20, 25°C using 1 cm 
quartz cuvettes. Temperature was controlled by a cooling jacket Julabo bath 
circulation thermostat (model F30-HC/8 Julabo Labortechnik, Seelback, Germany) 
connected to the spectrophotometer.   All solutions were prepared in distilled 
water. The concentration of pABA was held constant at 5×10
-5 
M. The 
concentration of α-CD varied from 0 to 5×10-3 M. The pH was controlled by 0.5 M 
phosphate buffers. Samples were incubated inside the spectrophotometer for 30 
minutes at the working temperature before recording the spectra.  
2.2.4 Phase Solubility diagram 
Phase-solubility diagrams allow evaluation of the affinity between α-CD and 
pABA in water. Phase solubility studies were performed according to the method 
reported by Higuchi and Connors [38]. pABA, in an amount that exceeded its 
solubility, was taken into a tube in which 10 ml of buffer (pH 6.0, 3.5, and 1.5) 
containing various concentrations of -Cyclodextrin (0-25 mmol) were added. 
These tubes were sealed and shaken at 25°C for 72 hours. This amount of time is 
considered sufficient to reach equilibrium. Subsequently, aliquots were filtered 
immediately through Whattman filter paper and diluted. A portion of the sample 
was analyzed by UV spectrophotometer to determine the solubility of pABA by 
means of pABA calibration curves. 
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2.2.5 Computational methods 
2.2.5.1 Ab initio geometry optimization  
Ab-initio energy minimization was performed on pABA in different 
ionization forms (neutral/zwitterionic, protonated, deprotonated) to better approach 
geometry of the different protonation states. Calculation was done with the 
Gaussian09 [39] program in the ground state using the 6-311G (5d, 7f) standard 
basis set and the B3LYP functional density method. Resulting geometries were 
compared with the crystal structure data retrieved from the Cambridge Structure 
Database (CSD).     
2.2.5.2 Semi-empirical simulation of complexes  
Starting geometry for the α-CD-pABA inclusion complex was based on the 
crystal structure obtained in this work. In a first step, all water molecules were 
removed. Two possible orientations for pABA inside the α-CD cavity were 
simulated: in orientation A, the carboxylic group (COOH) of pABA is located 
inside the α-CD cavity while orientation B corresponds to the amino group (NH2) 
inside the cavity [Fig 2.2.1]. Orientation B was generated by exchanging the 
carboxylic and amino groups from the starting X-ray crystal structure by means of 
the builder module (Vega ZZ [40]). The final structures were saved as PDB file in 
order to prepare a suitable format file (OpenBabelGUI [41]) to start semi-
empirical PM6* calculation (MOPAC2009 [42]). The input structures were edited  
*PM6 is a semi-empirical method for the quantum calculation of molecular electronic structure 
in computational chemistry. It is based on the Modified Neglect of Diatomic Overlap (MNDO), 
which in turn is based on the Neglect of Differential Diatomic Overlap integral approximation 
(NDDO). 
Hf = Etot + kBT 
Etot = Et + Er + Ev+ Ee 
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to adjust the protonation state of pABA: cationic form (extra H on the amino group 
and charge = +1), anionic form (no H on the carboxylic group and charge = -1), 
neutral form (protonated carboxylic group and unprotonated amine, charge = 0) 
and zwitterionic form (unprotonated carboxylic group and protonated amine, 
charge = 0)). The systems were energy optimized using the PM6 method to locate 
low energy structures of complexes. 
 
 
 
 
Fig 2.2.1 Two possible orientations of pABA (A and B) in α-CD (top), and pABA 
forms at different pH values (bottom). 
 
2.2.5.3 Effects of solvation on simulation of complexes. 
 In order to study the influence of solvation on the overall stability of the 
complexes, all the previous starting structures (orientations A or B with the 
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different protonation states for pABA) were placed in a 10 Å sphere containing 66 
water molecules and the same procedure of energy minimization (PM6 level) was 
applied on those solvated systems. [Fig 2.2.2] 
 
Fig 2.2.2 α-CD inclusion complex with pABA is placed in a 10 Å sphere 
containing 66 water molecules 
2.3 Results and discussion 
2.3.1 Crystal structure  
The structures of the host and guest molecules are given in Fig 2.3.1. Gn 
denotes the n
th
 glucosidic residue of the α-CD. In our crystal structure, α-CD forms 
a 1:1 inclusion complex with pABA [Fig 2.3.2]. 
2.3.1.1 Geometry of the host molecule 
 All glucose residues are in the normal 
4
C1 chair conformation, and the overall 
α-CD molecules show distorted hexagon geometry. The diagonal distance 
measured between the glycosidic oxygen atoms (O4n)   are O41
…
O44 = 8.289(2), 
O42
…
O45 = 8.221(2), and O43
…
O46 = 8.931(2) Å. A similar distorted structure was 
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observed for other α-CD complexes with phenyl derivatives [43]. Selected 
geometric parameters for the α-CD host molecule are listed in Table 2.3.1.  
The glycosidic O4n atoms lie in a plane within 0.0752 Å, the O4n
…
O4(n+1) 
distances varying between 4.103(2) and 4.468(2) Å, and the values of the angles 
between O4(n-1)
…
 O4n
…
O4(n+1) differing significantly from 120°, the ideal value for 
an angle in a regular hexagon. Indeed, these values range from 113.71(4)° 
to123.95(5)°, denoting that the cavity is distorted due to inclusion. The annular 
shape of α-CD is stabilized by inter-glucose hydrogen bonds connecting the 
secondary hydroxyl groups O3n and O2(n+1) of the neighboring glucosidic units 
[Table 2.3.1]  (average O3n
…
O2(n+1)  distance  2.849(2) Å, ranging from 2.708(2) 
to2.984(2) Å). The orientation of the C6n-O6n bond is described by torsion angles 
 
                        
Fig 2.3.1  Structure and numbering scheme of α-Cyclodextrin and p-Aminobenzoic 
acid. Only numbering of one glycosidic residue (Gn) of the α-CD is presented.  
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Fig 2.3.2  Axial view of the X-ray structure of the 1:1 host-guest inclusion 
complex of α-Cyclodextrin (α-CD) and p-Aminobenzoic acid (pABA). Water 
molecules are shown with light red color.  Hydrogen atoms were omitted for 
clarify. 
C4n-C5n-C6n-O6n and O5n-C5n-C6n-O6n, listed in Table 2.3.1. Most of the primary 
hydroxyl groups (major disordered site) adopt the gauche-gauche conformation 
(mean torsion angles C4n-C5n-C6n-O6n and O5n-C5n-C6n-O6n 49.9(3)° and -71.4(3)°, 
respectively) and point out the cavity. In G3 and G5, O6n are disordered in two 
sites with occupancy 60:40 % in G3 and 75:25 % in G5. A gauche-trans orientation 
is adopted for the second site and O6n points inside the cavity. Four ordered water 
molecules are situated outside the cavity at borders of the toroid rims and in 
interstices between α-CD molecules. Two water molecules, W2 and W4, are 
disordered in two sites with occupancy 50:50 % and 60:40 %, respectively. Table 
2.3.2 lists the hydrogen bonds in this complex. No direct hydrogen bonds were 
found between the host and its guest. 
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Table 2.3.1 α-CD macrocyclic characteristics.  
Residue D 
a
 (Å) φb (Å) dc (Å) D 
d 
(Å) 
Torsion angle (°) 
C4n-C5n-C6n-O6n 
Torsion angle (°) 
O5n-C5n-C6n-O6n 
G1 4.374 (2) 122.2 (1) -0.098(1) 2.821(3) 42.9(3) -78.6(3) 
G2 4.194 (2) 123.9 (1) 0.050(1) 2.708(2) 49.7(3) 70.5(3) 
G3 4.105 (2) 113.7 (1) 0.056(1) 2.804(2) 
51.5(12) 
175.9(15) 
-73.0(13) 
59.7(23) 
G4 4.468 (2) 122.8 (1) -0.113(1) 2.985(2) 52.4 (2) -69.9(3) 
G5 4.171 (2) 122.3(1) 0.064(1) 2.883(3) 
66.2(5) 
-153.3(17) 
-55.0(4) 
84.6(28) 
G6 4.149 (2) 114.6 (1) 0.040(1) 2.883(3) 46.3(3) -75.6(3) 
a
 Distance between atoms O4n...O4(n+1). 
b
 Angles between atoms O4(n-1)…O4n...O4(n+1). 
c
 Deviations (Å) from the least-squares optimum plan of the six O4n atoms. 
d
 Intramolecular hydrogen-bond distance between O3n…O2(n+1).  
 
2.3.1.2 Geometry of the guest molecule 
In the crystal structure, the anionic form of pABA is observed in the inclusion 
complex with α-CD. Indeed, no extra electron density peak is observed in 
difference Fourier maps neither close to the COO
-
 nor the NH2 groups that could 
account for an extra H atom. Deprotonation of the carboxylic function is further 
established by similar values for the two C-O bond lengths (1.255(3) and 1.275(3) 
Å). The carboxylate and the benzene ring are coplanar with torsion angles: O1 - C7 
- C1 - C2 = -0.1(5)°, O1 - C7 - C1 - C6 = -178.4 (3)°, O2 - C7 - C1 - C2 = 177.2(3)°, 
and O2 - C7 - C1 - C6 = -1.2(5)°. Non-hydrogen atoms in pABA lie in a plane 
within 0.0343 Å, favoring electronic delocalization and leading to a short CAr- C7 
distance equal to 1.473(4) Å. Delocalization is prolonged to the nitrogen atom with 
a short CAr-N distance equal to 1.398(3) Å, and a marked sp
2
 hybridization 
character of the nitrogen atom with valence angles:  C4 - N1 - H1N1=104.2(3.2) °, 
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Table 2.3.2 Hydrogen bonds in α-CD–pABA complex with H...A < r(A) + 2.0 Å 
and DHA > 110
°
. 
D-H A d(D-H) Å d(H..A) Å <DHA ° d(D..A) Å 
O21-H21O O36 0.820 2.12 155.6 2.883(3) 
O21-H21O O46 0.820 2.30 113.8 2.740(3) 
O22-H22O O24i 0.820 1.97 163.8 2.769(2) 
O23-H23O N1i 0.820 1.95 167.8 2.755(3) 
O24-H24O O33 0.820 2.03 156.4 2.804(2) 
O25-H25O O34 0.820 2.19 164.8 2.985(2) 
O25-H25O O44 0.820 2.33 113.7 2.762(2) 
O26-H26O O4WAii 0.820 2.02 158.6 2.801(6) 
O26-H26O O4WBii 0.820 2.34 119.8 2.839(9) 
O31-H31O O22 0.820 2.00 174.6 2.821(3) 
O32-H32O O23 0.820 1.91 166.8 2.708(2) 
O33-H33O O35i 0.820 2.03 133.6 2.666(2) 
O34-H34O O32iii 0.820 1.89 170.7 2.698(2) 
O35-H35O O26 0.820 2.11 157.0 2.885(3) 
O36-H36O O64iv 0.82 2.05 176.1 2.872(3) 
O61-H61O O33v 0.820 2.14 125.4 2.701(3) 
O62-H62O O65Avi 0.820 2.04 172.3 2.857(4) 
O62-H62O O4WBvii 0.820 2.63 126.0 3.179(9) 
O63A-H63A O65Aviii 0.820 2.19 155.0 2.956(4) 
O63B-H63B O2WB 0.820 2.33 127.3 2.90(1) 
O64-H64O O36ix 0.820 2.30 127.7 2.872(3) 
O65A-H65A O1Wii 0.820 2.07 166.5 2.872(4) 
O65B-H65B O21x 0.820 2.52 144.2 3.220(9) 
O66-H66O O34iv 0.820 2.23 133.1 2.853(3) 
N1-H1N1 O66xi 0.81(5) 2.21(5) 137(5) 2.861(3) 
N1-H2N1 O25i 0.95(5) 2.09(5) 171(5) 3.032(3) 
O1W-H1W1 O52 0.86(2) 2.26(3) 157(5) 3.063(3) 
O1W-H1W1 O65Avi 0.86(2) 2.48(5) 109(4) 2.875(4) 
O1W-H2W1 O4WBvii 0.82(2) 2.28(5) 125(4) 2.84(1) 
O3W-H1W3 O2xi 1.04(2) 1.73(4) 138(5) 2.601(6) 
O3W-H1W3 O1xi 1.04(2) 2.50(3) 152(4) 3.462(6) 
O3W-H2W3 O2WBxi 1.02(2) 1.49(5) 126(4) 2.248(9) 
O3W-H2W3 O2WAxi 1.02(2) 1.70(3) 158(5) 2.675(8) 
Symmetry: i [ x-1/2, -y+1/2, -z ], ii [ x+1, y, z ], iii [ x+1/2, -y+1/2, -z ], iv [-x+3/2, -y+1, z+1/2], v [ -x+1/2, -y+1, z+1/2 ], vi [ x-1, 
y, z ], vii [-x, y+1/2, -z+1/2], viii [ x-1/2, -y+3/2, -z ], ix [ -x+3/2, -y+1, z-1/2 ], x [-x+1, y+1/2, -z+1/2],  xi [ -x+1, y-1/2, -z+1/2 ]. 
A refers to the first occupied site of disordered O6n. 
B refers to the second occupied site of disordered O6n. 
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C4- N1 - H2N1= 108.7(3.7)°, and H1N1 - N1 - H2N1= 129.4(4.6)°.   
A general search in the CSD [23] of aromatic compounds containing a 
carboxylic or amino group, [Fig 2.3.3], confirms that the mean C−O bond lengths 
in Ar-COO
-
 fragments (1035 fragments retrieved) are 1.255(±0.022) and 
1.253(±0.028) Å, and the mean of CAr -Ccarb bond lengths is 1.509(±0.021)Å in 
case of the anionic forms (deprotonated). For Ar-COOH neutral forms (1259 
fragments retrieved) the bonds differ significantly with C=O and C−OH mean 
bond lengths of 1.227(±0.025) and 1.302(±0.025) Å, respectively, and the mean of 
CAr -Ccarb bond lengths is 1.485(±0.018) Å. The mean of CAr -N bond lengths in 
Ar-NH2 fragments (1696 fragments retrieved) is 1.396(±0.037) Å, and the mean of 
valence angles around N are: CAr-N-H1=115.1(±6.5)°, CAr-N-H2=115.1(±6.2)°, 
and H1-N-H2=115.3(±8.4)°. In Ar-NH3+ fragments (509 fragments retrieved) the 
mean of CAr -N bond length is 1.465(±0.014) Å, and the mean valence angles 
around of N are: CAr -N-H1= 110.157(±2.596)°, CAr -N-H2= 109.906(±3.195)°, 
CAr -N-H3= 110.0(±2.6)°, H1-N-H2=108.8(±4.4)°, H1-N-H3=108.8(±4.4)°, and 
H2-N-H3=108.6(±5.8)°. The bond lengths in our crystal pABA molecule are: 
1.255(3) and 1.275(3) Å for C−O in carboxylic group, 1.395(3) Å for CAr-N, and 
1.472(4) Å for CAr-C, in good agreement with the values associated with an 
anionic form of pABA. This is further confirmed by geometries optimized ab initio 
(B3LYP-6-311G (5d, 7f)) and with the semiempirical PM6 method for the 
different protonation states of pABA: neutral, cationic, anionic, and zwitterionic 
form [Table 2.3.3]. 
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Observed Car-C bond length is 1.4725 (40)Å 
Observed C-O1 and C-O2 bond lengths are: 
1.2554 (31)  and 1.2753 (35)Å. 
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Observed Car-C bond length is 1.4725 (40)Å 
Observed C-O1 and C-O2 bond lengths are: 
1.2554 (31)  and 1.2753 (35)Å. 
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Fig 2.3.3  Results of CSD search for Ar-COO
-
, Ar-COOH, Ar-NH2, and Ar-NH3
+
. 
 
Observed Car-N bond length is 1.3946 (33) Å 
Observed Car-N bond length is 1.3946 (33) Å 
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According to the values coming from the theoretical studies and taking into 
account the experimental values [Table 2.3.3]; it is clear that the anionic form of 
pABA must be adopted in our crystal structure. This conclusion opens the question 
of the type and position of the counter cation. No extra electronic density was 
observed in difference Fourier maps that could correspond to a cation. So we 
suggest that one of the water molecules could be protonated to serve as a counter 
cation of anionic pABA. 
Table 2.3.3 The bond lengths in carboxylic (or carboxylate) and amino (or 
ammonium) groups in different pABA form resulting from Ab-initio and PM6 
minimization.  
 C7-O1 (Å) C7-O2 (Å) C4-N1 (Å) C1-C7 (Å) 
pABA (Crystal structure) 1.2554 (31) 1.2753 (35) 1.3946 (33) 1.4725 (40) 
Anionic-pABA 
Ab-initio 1.28 1.28 1.41 1.53 
PM6 1.24 1.25 1.44 1.55 
Neutral-pABA 
Ab-initio 1.24 1.39 1.38 1.46 
PM6 1.21 1.39 1.39 1.46 
Zwitterionic-pABA 
Ab-initio 1.28 1.28 1.51 1.54 
PM6 1.23 1.23 1.50 1.56 
Protonated-pABA 
Ab-initio 1.23 1.37 1.51 1.49 
PM6 1.20 1.37 1.50 1.50 
 
2.3.1.3 Host-Guest Interaction 
In the crystal structure, pABA is deeply inserted into the cavity of α-CD, with 
the amino group protruding from the wide site of the cavity and the carboxyl at the 
narrow side as shown in Fig 2.3.2. The molecular plane of pABA forms an angle 
of 87.20(3)° with the plane made by the six O4n atoms of the α-CD. The mass 
center of the aromatic ring is 1.23 Å below the mass center of the O4n glycosidic 
atoms [Fig 2.3.4]. The corresponding values obtained from the β-CD-pABA 
inclusion complex are 72.3° and 1.64 Å [35]. As a consequence, the pABA 
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molecule better fits the α-CD cavity than the β-CD one, in agreement with results 
of studies in solution [28]. It is noteworthy that the location of the aromatic ring is 
similar in other α-CDs complexes with aromatic guests [24-26, 46-49]. This is 
probably due to the fact that this position is sterically favorable for the aromatic 
ring.  
          
Fig 2.3.4. Definition of the angle between molecular plane of pABA (in green) and 
the plane made by six glycosidic oxygen atoms O4n (in pink). 
Host-guest interactions play a crucial role in determining the orientation of 
guest molecules in the cavity of α-CD [44]. In the case of the pABA-α-CD 
complex, the guest is held in the host cavity mainly by van der Waals contacts 
(with α-CD) and hydrogen bonds (mediated through water molecules). Selected 
observed hydrogen bonds in the complex are listed in Table 2.3.2. The bonds listed 
in the table are those for which the distance between the acceptor and the hydrogen 
atom are smaller than the radius of the acceptor atom plus 2.0 Å, and the angle 
between the donor atom, the hydrogen and the acceptor atom is larger than 110°. 
No direct hydrogen bond is observed between α-CD and its included guest 
molecule. Indirect hydrogen bonds further stabilize pABA inside α-CD via water 
molecules. Additional hydrogen bonds involve the amino and carboxylic groups of 
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pABA and the hydroxyl groups of adjacent α-CD molecules, [Fig 2.3.5 and Table 
2.3.2].  
 
 
Fig 2.3.5 Hydrogen bonds network in a-CD –pABA inclusion complex. 
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2.3.1.4 Crystal packing 
 α-CDs molecules are arranged in the crystal cell nearly parallel to its ac 
plane, forming a molecular layer [Fig 2.3.6]. The least-squares plane through the 
six O4n atoms forms an angle of 5.7° with respect to the ac plane. This crystal 
arrangement is different from the cage-type structure [49-53] since both ends of the 
cavity are open to the space between the layers. The α-CDs molecules, which lie in 
the next layer, are slipped so that the overlap of the annular apertures is quite 
small. Therefore, in this arrangement, α-CDs molecules do not form a continuous 
channel such as the one found in other channel type structures [45,46,55]. The 
guest molecules are situated nearly parallel to the bc plane. The empty space 
between the α-CDs molecules is filled with four water molecules. Crystal packing 
is further stabilized by intra-layers hydrogen bonds formed between hydroxyl 
groups, by the hydrogen bonds formed between the guests and hosts from different 
layers, and by those formed between α-CDs molecules [Fig 2.3.5]. 
a) 
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b) 
 
Fig 2.3.6 Drawing of the packing of the complex, viewed along the a axis (a) and b 
axis (b).  
2.3.2 UV-Spectroscopy  
Absorption spectra (between 200 and 350 nm) of pABA in presence of 
increasing concentrations of α-CD are shown in Fig 2.3.7. In this wavelength 
range, pABA exhibits two maxima (284 and 222 nm) at pH=3.5. Addition of 
increasing amounts of α-CD to the aqueous pABA solution resulted in a small 
bathochromic shift and a significant increase in the pABA absorption. These 
results confirm that pABA forms an inclusion complex with α-CD in solution. 
Inclusion of the pABA molecule into the macrocyclic cavity is accompanied by 
changes in its environment, causing changes in the absorption and a bathochromic 
shift. 
In order to determine the stoichiometry and stability constant of the inclusion 
complex, the dependence of the pABA absorbance with respect to the α-CD 
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concentration was analyzed using the Benesi-Hildebrand equation [55]. Distinct 
equations are expected for a 1:1 (Eq. 1) or a 1:2 complex (Eq. 2) between pABA 
and α-CD. 
                                                                                                                     
                                                                                                                          ....(1) 
 
                                                                                                                           
....(2) 
  
Where  
- A and A0 are the absorption of pABA in presence and absence of α-CD, 
respectively;  
- Δε = εCD.pABA – εpABA is the difference in the molar absorptivities between free and 
complexed pABA;  
- CpABA and Cα-CD are the initial concentrations of pABA and α-CD, respectively;  
- K(1:1) is the stability constant of the 1:1complex. 
- K(2:1) is the stability constant of the 2:1complex.   
These equations can be rewritten in more useful forms (Eq. 3 and 4) which show a 
linear relationship between  and 
 
in the case of a 1:1 complex. 
 
                                                                                                                           ....(3)                                                                                      
 
 
                                                                                                            ....(4) 
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c)  
 
 
Fig 2.3.7 Absorption spectra of pABA: a) 12.5 ×10
-5 
at pH=1.5, b) 5×10
-5
 M at 
pH=3.5, c) 5×10
-5
 M at pH=6.0, in absence and presence of different 
concentrations of α-CD. 
 
In the case of pABA, stability constants of the complex were determined by 
measuring the change in maximum absorption of pABA (at ~280 and ~220 nm), 
ΔA, in the presence of increasing concentrations of α-CD. The dependency of ΔA 
on the α-CD concentration is shown in Fig 2.3.8. The data could be fitted to 
equation 3 corresponding to a 1:1 stoichiometry. From these data, complexation 
constant, Kc, of pABA by α-CD is estimated to 2319.4±241.0 and 596.0±80.5 M
-1
 
at pH=3.5 and 1.5 respectively at T= 25°C. Values of 1400±35 and 1000±148 M
-1
 
were obtained at pH=3.5 and 2.0 (T=20°C), respectively, by fluorescence method 
[56]. 
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Repeating the same procedure at different temperatures (4, 10, 15, 20, and 
25°C) showed that the stability constant increases with decreasing temperature 
Table 2.3.4. 
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Fig 2.3.8 Dependence of ΔAmax of pABA solutions (5×10
-5
 M at pH=3.5 and 
12.5×10
-5
 at pH= 1.5) on the α-CD concentration. Benesi-Hildebrand plots (linear 
relationship between 1/ΔA and 1/Cα-CD and  non linear relationship between 1/Δa 
and  1/(Cα-CD)
2
 ) assuming formation of a 1:1 complex between pABA and α-CD 
give access to stability constants of the complex.  
 
Table 2.3.4 Stability constants Kc (M
-1
) for pABA-α-CD complex at pH=3.5 and 
different temperatures. 
 4 °C 10 °C 15 °C 20 °C 25 °C 
c l max=222 nm) 
M
-1 
3155.4±298.3 2972.7±317.3 2854.9±317.5 2698.3±314.6 2503.2±272.2 
c l max=284 nm) 
M
-1 
2880.2±188.3 2686.1±121.4 2505.2±155.6 2414.7±232.0 2319.4±241.0 
 
 
Use of the Van’t Hoff equation gives direct access to H° and S° of complex 
formation, [Fig 2.3.9 and Table 2.3.5]. The data presented in Table 2.3.4 and Table 
2.3.5 indicates that the complex formation of pABA with α-CD is exothermic. 
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Fig 2.3.9 Van't Hoff analysis (dependence of Ln(K) of pABA-α-CD complex 
formation on the temperature (1/T) at  pH=3.5 (K values determined from data at 
λmax= 284 and 222 nm) give access to thermodynamic parameters ΔH° and ΔS° for 
the 1:1  complex formation of  pABA with α-CD . 
 
Table 2.3.5 ΔH° and ΔS° of complex formation, calculated from UV-spectroscopy 
data at pH=3.5. 
 lmax  = 222 nm lmax  = 284 nm 
H° (kJ.mol-1) -8.69±0.88 -6.25±0.31 
S° (J.K-1.mol-1) 35.9±3.1 43.5±1.1 
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Thus, the complex of pABA with α-CD is enthalpy-entropy stabilized. 
Enthalpy and entropy values include the contributions from the following main 
processes: 
1) Partial breaking of the hydration shells of the solutes. 
2) Exclusion of cavity-bound water molecules that are considered as 
“enthalpy-rich” [57]. 
3) Conformational changes (e.g. deviation from symmetry and restriction of 
conformational flexibility). 
4)  Direct binding due to non-covalent interactions (van der Waals 
interactions, H-bonding, hydrophobic effects, electrostatic interactions) 
[57]. 
5) Hydration of complex. 
The observed small H° value [Table 2.3.5] may be a result of the important 
role of hydrophobic effect and dehydration of the solutes occurring upon 
penetration of the pABA molecule into the hydrophobic cavity of α-CD. This 
happens when the guest molecule is deeply inserted into the Cyclodextrin cavity, 
as can be seen from the crystal structure of the complex. Positive entropy changes 
[Table 2.3.5], underline the extensive dehydration accompanied by the release of 
water molecules from the solvation shells of reagents into the bulk aqueous 
solution. Furthermore, van der Waals contacts of pABA with the apolar cavity of 
cyclodextrin can play a significant role in the complexation process, resulting in a 
positive S° [57]. 
2.3.3 Phase Solubility diagrams  
An apparent stability constant (Kc) can be calculated from the phase solubility 
diagrams using the equation 5, according to the hypothesis of a 1:1 stoichiometric 
of the complex [38]. 
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)1(0 SlopeS
Slope
Kc


 
                                                                                                                         …. (5) 
 
The slope was obtained from the initial straight line portion of the plot of the 
pABA solubility against the α-CD concentration, and S0 is the equilibrium 
solubility of pABA in water. Phase-solubility diagrams for the complex formation 
between pABA and α-CD are presented in Fig 2.3.10. Our data indicate that the 
solubility of pABA in water depends on the pH of the solution: it is higher for the 
charged (protonated (pH = 1.5) and unprotonated (pH = 6)) forms: S0 = 0.145, 
0.030, and 0.170 M
 
at pH = 1.5, 3.5, and 6.0, respectively. The phase-solubility 
diagrams show that the aqueous solubility of pABA increases linearly as a function 
of the α-CD concentration.  
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Fig 2.3.10 Phase solubility diagrams of pABA-α-CD system at pH=3.5, 1.5, and 
6.0. 
The linear host-guest correlation with a slope of less than 1 confirms the 
formation of a 1:1 complex in solution with respect to -CD concentration. The 
increase in solubility of pABA resulting from inclusion in -CD is more important 
at pH 3.5 (compare slopes). This study shows that the complex between pABA and 
-CD is more stable at pH=3.5, with an apparent stability constant, K(1:1), obtained 
from the slope of the solubility diagrams, of 736.9±132.4 and 1710.7±219.6 M
-1
 at 
25 and 4°C respectively.  
2.3.4 Semi-empirical simulation of complexes 
pABA can exist in three forms (neutral, anion and cation) according to the pH 
of the environment [Fig 2.2.1]. Ab initio (B3LYP-6-311G (5d,7f)) calculations 
have been applied to optimize the geometry of the different protonation forms of 
pABA alone. The results were used as a complement to crystal structures retrieved 
from the CSD to analyze the crystal structure of this guest in α-CD (see point 
2.1.2). Similar results have been obtained using the PM6 semi-empirical method. 
Based on those calculations, the most stable form is the protonated state  (EB3LYP = 
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-476.394 A.U. (-12963.16 eV); EPM6 = -1721.625 eV) followed by the neutral and 
zwitterionic states (EB3LYP = -476.170 (-12957.06 eV) and -476.064 A.U. (12954.18 
eV); EPM6 = -1715.149 and -1712.645 eV, respectively). The anionic form is the 
less stable (EB3LYP = -475.604 A.U. (12941.66 eV); EPM6 = -1703.001 eV). 
Interestingly, it is this last form that is observed in the crystal structure of the 
inclusion complex with -CD, illustrating the fact that stabilization effects 
resulting from complexation by the Cyclodextrin do affect differently the distinct 
protonation forms of pABA.  
Therefore, different structures of α-CD-pABA inclusion complexes have been 
simulated. Two possible orientations of pABA inside the α-CD cavity have been 
retained, one (orientation A) with the carboxylic group of pABA located inside the 
α-CD cavity and the other (orientation B) corresponding to the amino group inside 
the cavity. For both orientations, the different protonation states of pABA 
(protonated, anionic, neutral, or zwitterionic) were considered. Effect of solvation 
on the overall stability of the complexes was also approached. Energy 
minimization of the different complexes was performed (PM6 level). 
The optimized geometries were reasonable when water molecules where 
included in the calculation. In the absence of explicit water molecules, the in 
vacuum optimized complexes with neutral pABA (orientation A) or zwitterionic 
pABA (orientation B) converged to distorted geometries. This is in agreement with 
a similar study performed on inclusion complexes of pABA and -CD [58]. All the 
other systems converged to chemically reasonable complexes, suggesting that the 
PM6 method is well adapted to study the pABA-CD systems. In particular, the 
PM6 method reproduced the crystal structure rather well. Indeed, the enthalpy of 
formation of pABA included in α-CD was the most negative with the anionic form 
of pABA, in orientation A (ΔHf(PM6) = -158.77 kcal) compared to the anionic form 
- 90 - 
 
of the guest in orientation B ( ΔHf(PM6)  = -142.78 kcal). This result is in excellent 
agreement with the crystal structure reported in this study. The PM6 method 
suggests that complexation of the anionic form is favored compared to the other 
protonation states of pABA (ΔHf(PM6) =  -158.77,  -129.90, -111.95,   and  +81.25 
kcal) for complexes with anionic pABA
-
, zwitterionic pABA
+/-
 , neutral pABA, 
and cationic pABA
+
 forms, in orientation A. Similar calculations performed on 
complexes including pABA and -CD [58] led to different results. In that work, 
orientation B was more stable but, in agreement with our results, the complex with 
anionic pABA was favored. The geometries of the studied complexes found with 
the PM6 method confirm that pABA is deeply included in -CD, with the aromatic 
ring for each species of pABA totally embedded in the α-CD cavity especially for 
the A orientation.  
2.4 Conclusions 
Our crystallography study shows that pABA forms a 1:1 complex with α-CD 
and is deeply included into the cavity of the cyclodextrin, with the amino group 
protruding from the wide site of the cavity and the (unprotonated) carboxylate at 
the narrow side. The crystal structure corresponds to the anionic form of pABA. 
The pABA guest is held in the host cavity mainly by van der Waals contacts and 
hydrogen bonds.  Spectroscopic studies of the interactions of pABA with α-CD 
demonstrate the insertion of pABA into the Cyclodextrin cavity in solution, with 
formation of a 1:1 inclusion complex with stability constant 2319.4±241.0 M
-1
 at 
25°C and pH=3.5. The phase solubility studies confirm the formation of a 1:1 
pABA-α-CD inclusion complex. The solubility of pABA in water is markedly 
enhanced by complexation with α-CD. The calculations carried out with the PM6 
method show that inclusion complexes of different pABA protonation states with 
α-CD lead to stable structures and this confirms experimental observations. During 
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this theoretical study, orientation A (carboxylic group inside) was more favorable 
than orientation B (amino group inside), in agreement with our crystal structure. 
2.5 Supplementary data 
Tables of atomic coordinates, bond lengths, and bond angles have been 
deposited with the Cambridge Crystallographic Data Center, CCDC Nos. 845857 
for the α-CD–pABA complex. These data may be obtained free of charge, on 
request, from The Director, Cambridge Crystallographic Data Center, 12 Union 
Road, Cambridge, CB2lEZ, UK (fax: + 44-1223-336033; e-mail: 
deposit@ccdc.cam.ac.uk or www: http://www.ccdc.cam.ac.uk). A copy of 
electronic files is also supplied on the CD available as annex to this thesis.  
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Chapter 3 
Using Cyclodextrin as linker in Metal-Organic Frameworks 
(MOFs) for drugs carriers and molecular absorption  
 
3.1 General introduction 
Metal-Organic Frameworks (MOFs) are crystalline compounds built from 
metal ions or clusters coordinated to predominately rigid organic molecules. They 
form one-, two-, or three-dimensional structures (Fig 3.1.1) that are often porous. 
The synthesis and characterization of MOFs is one of the most rapidly 
developing areas of chemical science now. These materials have unquestionably 
enormous potential for many practical applications. MOFs attract attention as 
materials for adsorptive hydrogen (energy storage) because of their exceptionally 
high specific surface areas and chemically tunable structures [1]. Hydrogen 
molecules are stored in a MOF by adsorbing to its surface. Compared to an empty 
gas cylinder, a MOF-filled gas cylinder can store more gas because of adsorption 
that takes place on the surfaces. Furthermore, MOFs have a fully reversible uptake-
and-release behavior: since the storage mechanism is based primarily on 
physisorption, there are no large activation barriers to be overcome when liberating 
the adsorbed hydrogen [2]. In addition to the above, several possible applications 
of MOFs are also found as drug-delivery, sensors, luminescence materials, 
magnetic materials, catalysis, gas separations, etc. [3] 
 MOF, generally, is composed of two major components: a metal ion (or 
cluster of metal ions) and an organic molecule called a linker. The choice of metal 
and linker has significant effects on the structure and properties of the MOF. For 
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example, the metals coordination preference influences the size and shape of pores 
by dictating how many ligands can bind to the metal and in which orientation. The 
organic linkers are typically mono-, di-, tri-, or tetravalent ligands [2]. Many 
linkers or ligands are known in synthesis of MOFs. In the early years of MOFs 
research, mostly simple and readily available organic linkers were utilized in MOF 
synthesis; we enumerate, for example but not limited to, oxalic acid, malonic acid, 
succinic acid, glutaric acid, phthalic acid, isophthalic acid, citric acid, and squaric 
acid. In recent years the targeted synthesis of specifically functionalized linkers has 
become a major object of research [4-12]. The utilization of such functionalized 
linkers can significantly change the properties of synthesized MOFs.    
 
Figure 3.1.1: Simple scheme showing three possible forms (1D, 2D and 3D) of 
MOFs.  M = Metal cation, L = Linker. 
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Until recently, only a handful of MOFs have been derived from natural 
products. Recently, several works have been reported on this topic [13-15]. 
Stoddart et al. show in their pioneering works the fact that a common feature of all 
the polyoxygenated ligands which bind alkali and alkaline earth metal cations are  
‒OCCO‒ repeating units with gauche conformations defining their C‒C bond [Fig 
3.1.2]. This geometry orients the hard oxygen donors in a manner which allows 
them to interact seamlessly with hard Group IA and IIA metal cations and is 
undoubtedly responsible for the strong monopole‒dipole interactions that lead 
cooperatively to large association constants for complexes incorporating a number 
of them. For example, [18]crown-6 was found to bind K
+
 ions in methanol with a 
stability constant (Ka) in excess of 10
6
 M
-1
, diazamacrobicyclic polyethers like 
[2.2.2]cryptand were shown by Lehn and Sauvage to exhibit Ka values as high as 
10
15
 M
-1
 for the binding of alkali metal cations in methanol.[16-23] Smaldone et al, 
also, expected that α1,4-linked D-glucopyranosyl residues which constitute the 
repeating units in cyclodextrin display the ‒OCCO‒ binding motif on both their 
primary and secondary faces, in addition to their hollow structure, augurs well for 
their being able to form extended structures with Group IA and IIA metal cations. 
In spite of there is little or no evidence that cyclodextrins bind alkali and alkaline 
earth metal cations strongly in aqueous solution, they have, actually, prepared a 
beautiful and brilliant structure of a MOF comprised of γ-cyclodextrin (γ-CD) 
rings coordinated to alkali metal, producing highly porous materials from 
completely nontoxic and naturally occurring materials [24-25]. The overall 
topology of the resultant MOF is cubic with extended linear pores along their 
crystallographic axes. The complexes were prepared simply by combining 1.0 
molar equivalent of γ-CD with 8.0 molar equivalents of KOH in aqueous solution, 
followed by vapor diffusion of MeOH into the solution during 2–7 days. In this 
structure eight-coordinate M
+
 ions assist in the assembly of (γ-CD)6 cubes. The six 
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γ-CD units occupy the faces of a cube and link these cubes to form a three 
dimensional MOF having open porous of 1.7 nm diameter in an extended fashion 
accessible one to the other. Six pore windows of 0.78 nm diameter are defined by 
the γ-CD tori which adopt the faces of the cube and the framework has an 
estimated total pore volume of 54% [Fig 3.1.2 (c)].    
 
           
 
 
 
 
 
 
Figure 3.1.2: Examples of polyoxygenated compounds which can be used to coordinate alkali or 
alkaline earth metal cations. In all cases, the ‒OCCO‒ or ‒OCCN‒ bidentate moieties, capable of 
chelation to hard Group IA and IIA metal cations, are colored in red. (a) The structural formula 
of 18-crown[6] and the crystal structure of its 1:1 complex with a K
+
 ion. (b) The structural 
formula of [2.2.2]cryptand, and the crystal structure of its 1:1 complex with a K
+
 ion. (c) One of 
the eight α1,4-linked D-glucopyranosyl residues which comprise γ-CD, with the two possible ‒
OCCO‒ coordination sites highlighted in red and the possible modes of coordination of K+ ions 
to the primary and secondary faces of γ-CD in the crystal structure. The crystal structures were 
redrawn from CCDC depositions KOSRAL [26] and KCRYPT10 [27] and [24] respectively, 
with counterions and hydrogen atoms removed for clarity. 
There are also a number of solid-state structures in literatures in which the 
coordination of these cations by cyclodextrins has been observed. Both Group IA 
and IIA metal cations have been shown to link molecules of α-CD, β-CD and γ-CD 
by coordinating (i) to their primary hydroxyl groups, [28], (ii) to their secondary 
hydroxyl groups, [29-32] or (iii) to a combination of both of these binding sites. 
(a) (b) (c) 
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[24, 25, 33-39]. The wide range of coordination geometric shapes which have been 
observed, results presumably from the absence of preorganization of the numerous 
oxygen atoms that are capable of coordinating to the metal cations. 
In this context, and as part of our study plans to prepare inclusion complexes 
systems between cyclodextrins and aminobenzoic acids as drugs models, we 
performed a study on the cyclodextrin MOFs (CD-MOFs) formed by coordinating 
the cyclodextrins to potassium cation. One original structure of MOFs is reported 
here. We have also decided to take the advantages of this interaction between 
cyclodextrin and alkali metal cation to favour formation of inclusion complexes as 
drug carrier, after failing to prepare these kinds of complexes in the conventional 
way. In this work, we report a strategy to overcome this problem using 
cyclodextrin MOFs and we are looking forward to show how the alkali metal 
cation can play a cofactor role for preparation of such inclusion complexes. 
3.2 Results and discussion 
3.2.1 α-CD-KOH MOF 
α-CD forms, easily, a 1:2 complex with KOH [Figure 3.2.1(a)]. This complex 
crystallizes in orthorhombic P212121 space group. The cyclodextrin adopts a cage 
structure and crystal packing is stabilized by oxygen atoms that coordinate 
potassium cation and intermolecular and intramolecular hydrogen bondings. This 
structure is of general interest in the context of polymorphism of cyclodextrins and 
the coordination of the metal cation by the cyclodextrin is of particular interest 
with respect to formation of original Metal-Organic Frameworks (MOFs).  
The overall structure of α-CD is consistent with its other crystal structures. 
The torsion angles defining the orientation of C(6)‒O(6) bonds show two different 
types of conformation: gauche-trans for G3 and G4 and gauche-gauche for the 
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other residues. The particular orientation of the C(6)‒O(6) bonds of the G3 and G4 
residues probably results from hydrogen bonding of the primary O(63) and O(64) 
with water molecules O1W and O2W which in their turn are hydrogen bonded to 
the included methanol guest [Figure 3.2.1(b)]. 
                 
                                       a                                                 b 
Figure 3.2.1. (a) 1:2 complex of α-CD with KOH. (b) The particular orientation of the C(6)‒O(6) 
bonds of the G3 and G4 residues results from hydrogen bonding with water molecules O1W and 
O2W which in their turn are hydrogen bonded to the included methanol molecule. Hydrogen 
atoms and solvent molecules were omitted for clarity. 
 
The α-cyclodextrin molecules form, through 21 axes, a closed herringbone-
like pattern along ac plane as monomer units Figure 3.2.2. This arrangement is 
stabilized by coordination to potassium ions and by hydrogen bonds. Strong inter- 
and intra-molecular hydrogen bondings involve hydroxyl groups and water 
molecules [Table 3.2.1].  
The environment of both potassium ions is comprised of eight O atoms 
coming mainly from hydroxyl groups. The majority of distances [Table 3.2.2] are 
longer than the sum of the ionic radii of K and O (2.66 Å). Methanol occupies the 
cavity of the α-cyclodextrin and is stabilized by H bonds with two water molecules 
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O1W and O2W which are in hydrogen bonding distance with the two hydroxyl 
group in G3 and G4. 
Table 3.2.1. Hydrogen Bonds in α-CD-KOH complex. 
 
D‒ H A D‒H (Å) H…A (Å) D…A (Å) D‒H…A (°) 
O1W-H1W1 O1M 0.94 1.810 2.57 (1) 136.5 
O1W-H2W1 O64 0.79 2.090 2.50 (1) 112.2 
O2W-H1W2 O1M 0.86 1.970 2.78 (1) 155.5 
O2W-H2W2 O63 0.86 2.100 2.92 (1) 161.3 
O3W-H1W3 O1Wi 0.87 2.120 2.65 (1) 118.5 
O3W-H2W3 O61ii 0.86 1.910 2.770 (4) 178.8 
O4W-H1W4 O56iii 0.87 2.200 2.915 (4) 138.7 
O4W-H1W4 O66iii 0.87 2.590 3.133 (4) 121.0 
O4W-H2W4 O2Wi 0.87 1.840 2.708 (5) 179.1 
O5W-H1W5 O62iv 0.91 2.590 3.459 (3) 160.0 
O5W-H2W5 O1C 0.87 1.777 2.597 (3) 155.5 
O21-H21O O36 0.82 1.988 2.800 (3) 170.4 
O21-H21O O46 0.82 2.458 2.855 (3) 110.8 
O22-H22O O1Civ 0.82 1.840 2.642 (3) 165.2 
O23-H23O O32 0.82 2.073 2.881 (3) 168.2 
O23-H23O O42 0.82 2.344 2.771 (3) 113.2 
O24-H24O O33 0.82 2.023 2.831 (3) 168.2 
O24-H24O O43 0.82 2.369 2.766 (3) 110.6 
O25-H25O O1Cv 0.82 1.800 2.609 (3) 168.9 
O26-H26O O3Cvi 0.82 1.688 2.508 (3) 177.4 
O31-H31O O22 0.82 1.950 2.768 (3) 175.6 
O31-H31O O41 0.82 2.560 2.910 (3) 107.5 
O32-H32O O3Civ 0.82 1.861 2.673 (3) 170.5 
O33-H33O O2C 0.82 1.970 2.740 (3) 156.1 
O34-H34O O25 0.82 2.049 2.868 (3) 176.7 
O34-H34O O44vii 0.82 2.520 2.882 (3) 108.0 
O35-H35O O26 0.82 1.956 2.757 (3) 165.2 
O35-H35O O45 0.82 2.580 2.936 (3) 108.2 
O36-H36O O24vi 0.82 2.351 2.924 (3) 127.5 
O61-H61O O2Cviii 0.82 2.025 2.810 (3) 160.2 
O62-H62O O4Wiii 0.82 1.868 2.661 (4) 162.5 
O63-H63O O5Wix 0.82 2.050 2.854 (3) 166.2 
O64-H64 O24x 0.82 2.342 3.027 (6) 141.4 
O65-H65O O62v 0.82 1.863 2.673 (3) 169.3 
O66-H66O O5Wviii 0.82 2.021 2.814 (3) 162.7 
Symmetry : i[ x-1, y, z ], ii[ -x, y-1/2, -z+5/2 ], iii[ -x, y+1/2, -z+5/2 ], iv[ x-1/2, -y+3/2, -z+2 ], v[ 
x, y-1, z ], vi[ x-1/2, -y+1/2, -z+2 ], vii[x,1+y,z], viii[ -x+1/2, -y+1,z+1/2 ], ix[ x+1/2, -y+3/2, -z+2 
], x[ x+1/2, -y+1/2, -z+2 ] 
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Table 3.2.2 Potassium coordination in α-CD-KOH complex. 
 
Analysis of the title compound crystal structure shows the presence of 
carbonate. The geometry of the ion is compatible with a fully deprotonated 
carbonate ion (-2), as confirmed by a search performed in the CSD and comparison 
of the bond lengths in the reported crystal structure. The carbonate forms the 
counter-ion of two potassium cations. As for the source of carbonate in the 
structure, there are two possibilities: it might be coming from non-pure potassium 
hydroxide (85%); alternatively, it may be the result of the contact of atmospheric 
carbon dioxide with the alkali solution. 
 
K1 K2 
M‒L Bond length (Ǻ) M‒L Bond length (Ǻ) 
K01—-O23 2.649 (2) K02—-O34i 2.718 (3) 
K01—-O65i 2.741 (2) K02—-O31 2.790 (2) 
K01—-O35i 2.850 (2) K02—-O3W 2.884 (3) 
K01—-O5W 2.951 (2) K02—-O21 2.913 (2) 
K01—-O2C 2.955 (2) K02—-O4W 2.958 (4) 
K01—-O53ii 3.027 (2) K02—-O24i 3.160 (3) 
K01—-O25iii 3.331 (2) K02—-O63iv 3.225 (2) 
K01—-O55i 3.362 (2) K02—-O66v 3.253 (3) 
Symmetry : i[x-1/2, -y+1/2, -z+2], ii[x-1/2, -y+3/2, -z+2], iii[x, y+1, z], iv[x-1, y, z], v[-x, y+1/2, -z+5/2] 
- 104 - 
 
       
a                                       b                                     c 
      
d                                                              e 
Figure 3.2.2 (a, b, c) Crystal packing, in α-CD-KOH complex, in a, b and c direction 
respectively. (d, e) Potassium coordination in α-CD-KOH complex. 
 
3.2.2  New polymorph of α-CD 
Irina et al showed in their 
1H NMR study on CDs complexes that α-CD and β-
CD form 1:1 inclusion complexes with para and meta-aminobenzoic acid (pABA 
and mABA) and they discussed the influence of the cyclodextrin cavity size and 
position of the side amino group in the aromatic ring of aminobenzoic acid 
molecule on the binding mode and the complex stability [40]. In spite of this 
evidences on the formation of inclusion complexes between CDs and ABA family, 
all our tireless efforts to produce these complexes in crystalline state by 
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conventional ways ended in failure with the exception of para-aminobenzoic acid 
(pABA), which was easily prepared from water/ethanol solution by slow 
evaporation. This has been discussed in detail in chapter1, and compared with the 
two known structures of β-CD with pABA and oABA (the two structures are, 
already, known in literatures [41]). In fact all our effort to make complexes 
between α-CD and oABA and mABA result in a new form of α-CD with crystals 
having a hexagonal external shape [Figure 3.2.3(a)], and a hexagonal R3 internal 
crystal system [cell parameters: a = b = 23.6696(4)Å, c = 109.0704(15)Å, α = β = 
90° and γ = 120°, the structure converged at R1 = 0.0774 for 29042 [Fo > 4σ(Fo)] 
and  0.0873 for all  34303 data after applying squeeze refinement procedure to 
treat the problem with the disordered solvent inside the structure].  
In this structure, the asymmetric unit contains 12 × one third α-CD molecules 
and 43 water molecules, most of these waters positions are not fully occupied due 
to disorder. The rest of the molecules are generated by the 3-fold axis. The average 
bond-length and angles are in the correct range and similar to those in the other α-
CD structures. All glucose residues are in the normal 
4
C1 chair conformation, and 
the overall α-CD molecules show nearly regular hexagon geometry, the 
O4n…O4(n+1) distances varying between 4.179(5) and 4.296(6) Å, and the values of 
the angles between O4(n-1)… O4n…O4(n+1) being close to 120°, the ideal value for an 
angle in a regular hexagon. Indeed, these values range from 118.6(1)° to 121.5(1)°, 
denoting that the cavity is not  distorted due to absence of inclusion with big 
molecules. The annular shape of α-CD is stabilized by inter-glucose hydrogen 
bonds connecting the secondary hydroxyl groups O3n and O2(n+1) of the neighboring 
glucosidic units. The hexagonal diagonal distances, measured between the 
glycosidic oxygen atoms (O4n), range from 8.408(4) to 8.483(5) Å. α-CD displays 
a porous structure consisting of long channels resulting from stacking of molecules 
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in head to head trimers extended along the c-axis [Figure 3.2.3(b,c)]. All their 
glucosidic (O4n) planes are parallel to ab plan.  
   
                          (a)                                                          (b) 
 
(c) 
Figure 3.2.3 (a) hexagonal shaped crystals of a-CD-new polymorph, (b,c) long channels formed 
by stacking of α-CD molecules in head to head trimers extended along the c-axis. Hydrogen 
atoms and solvent molecules were omitted for clarity. 
 
We were able to calculate an approximate value for the void volume inside the 
structure using the contact surface with a 1.2 Å probe radius in Mercury software. 
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This calculation resulted in a unit cell void volume of 16131.35Å
3
 and equal to 
30.5% of the structure. This might give potential application in the field of gas 
storage and molecular absorption. 
3.2.3 Crystal structures of α-CD.KOH-ABA complexes 
Going back to our subject, the establishment of an inclusion complex systems, 
we decided to use both properties of cyclodextrin, i.e., the ability of CDs to form 
inclusion complexes by mean of their hydrophobic cavity, and to form MOFs with 
alkali metal cations by mean of their multiple ‒OCCO‒ binding motifs, in order to 
develop a new strategy to capture ABA molecules inside the cyclodextrins cavities. 
This strategy is based on two main steps:  
1) The first step is preparation of a salt from ABA and KOH. 
2) The second step aims to construct MOFs by mixing this salt with CD. This 
has to stabilization of the ABA
-
 ions, which form the contortions for K
+
 cations, 
inside the MOFs network.  
This strategy has enabled us to prepare two α-CD inclusion complexes in 
MOFs with both mABA (MOF-1) and oABA (MOF-2) in presence of KOH. The 
structures belong to the monoclinic P21 space group with unit cell dimensions:         
a = 16.4499(5), b=14.1657(4), c = 23.5031(6) Å and β = 93.206(2) in MOF-1 
a = 14.1031(6), b = 23.3959(8), c =16.6293(7) Å and β = 95.139(4) in MOF-2. 
The basic building block, in these two crystal structures, is a box designed by two 
α-CD molecules forming a head-to-head dimer containing the ABA ions inside the 
cavity. K
+
 cations, in this case, play role as a lock to this box and a link with the 
other boxes to construct a long 1D MOFs, as shown in Figure 3.2.4. We think that 
the formation mechanism of these systems is based on the electrostatic attraction 
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Figure 3.2.4 Simple scheme shows 1D MOFs constructed by linking boxes formed by two α-CD 
molecules in a head-to-head dimer by potassium cations and containing the ABA ions. 
 
between opposite ions as the planar negative ions (ABA
-
) help in alignment of both 
α-CD molecules to form a dimer and then attracting potassium cations to fix and 
lock this dimer. Or vice versa, where the potassium cations link α-CD molecules 
and then they attract ABA
-
 ions to take place within the cavity. Both assumptions 
are powered by the previous results: it was found that the α-CD easily reacts with 
potassium cations, while all our attempts to prepare the complex in the absence of 
potassium hydroxide lead to a hexagonal structure with channels built by stacking 
of α-CD molecules in the form of head to head trimers. This underlines the role 
played by the planar ABA molecules in guidance of α-CD stacking [Figure 
3.2.3(c)]. 
Two α-CD molecules,  A and B, form a head-to-head dimer  in both MOF-1 
and MOF-2 [Figure 3.2.5], in which the glycosidic (O4n) atoms lie in a plane 
within 0.0373 and 0.1630Å in MOF-1 and 0.0822 and 0.2203Å in MOF-2, for 
molecule A and B respectively, [Figure 3.2.6 (a,b)]. These two glycosidic (O4n) 
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plans in A and B molecules make an angle 10.68(3) ° in MOF-1 and 4.61(3) ° in 
MOF-2. The corresponding distance from center to center of the two O4n planes is 
7.256 Å in MOF-1 versus 7.336Å in MOF-2. All glucose residues, in both MOFs, 
are in the normal 
4
C1 chair conformation, and the overall α-CD molecules show 
distorted hexagon geometry. This appears more clearly in molecule A in both 
MOF-1 and MOF-2, where the diagonal distance measured between the glycosidic 
oxygen atoms (O4n) range from 8.203(5)-8.786(5) Å and 8.432(5) - 8.494(5) Å in  
      
a                                                              b 
      
c                                                              d 
Figure 3.2.5 The structures of α-cyclodextrin MOFs with (a,b) m-aminobenzoate potassium and 
(c,d) o-aminobenzoate potassium. Hydrogen atoms and solvent molecules were omitted for 
clarify. 
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                              a                                                       b 
Figure 3.2.6 Definition of the planes made by six glycosidic oxygen atoms O4n (in red): (a) with 
mABA, (b) with oABA. 
the molecules A and B respectively for the MOF-1, and from 8.150(7)-8.641(7)Å 
and 8.121(7)-8.598(7) Å in the molecules A and B respectively for the MOF-2. A 
similar distorted structure was, also, observed in other α-CD complexes [42]. The 
O4n…O4(n+1) distance varies between 4.094(5)- 4.401(5) Å and 4.180(5)- 4.331(6) 
Å, and the O4(n-1)…O4n…O4(n+1) angles range from 115.4(1)-122.9(1)° and 
113.1(1)-121.6(1)° in the molecules A and B respectively for the MOF-1. These 
distances range from 4.112(7)-4.272(7)Å and 4.024(7)-4.336(7) Å, and the angles 
range from 114.8(2)-124.2(2)° and 117.0(2)-125.1(2)° in the molecules A and B 
respectively for the  MOF-2 [Table 3.2.3]. 
The annular geometry of α-CD molecules is stabilized by interglucose 
O3n…O2(n + 1) hydrogen bonds with O…O distances ranging from 2.723(2)-3.620(1) 
Å in MOF-1 and from 2.735(4)-3.524(1)Å in MOF-2. There are 5 water molecules 
located outside the α-CD cavities beside of 7 methanol molecules. Three of them 
occupy the centers of  α-CD  cavities and the rest are located at the edges  of  α-CD 
- 111 - 
 
Table 3.2.3 α-CD macrocycle characteristics. 
MOF-1 
α-CD Molecule Residue Da(Å) φb(°) dc(Å) T1
d
(°) T2
e
(°) 
A 
G1 4.262(7) 121.5(1) 0.018(3) 57.0(7) -65.7(6) 
G2 4.112(7) 122.9(1) 0.031(3) 47.4(7) -72.5(6) 
G3 4.248(7) 115.6(1) -0.047(3) 57.6(6) -65.1(6) 
G4 4.272(7) 121.7(1) 0.012(3) 54.5(6) -69.1(5) 
G5 4.215(7) 122.8(1) 0.040(3) 
-171.9(6) 
42.5(9) 
70.6(7) 
-75.0(7) 
G6 4.255(7) 115.4(1) -0.055(3) 58.7(6) -63.2(6) 
B 
G1 4.254(7) 118.5(1) -0.183(3) 60.5(7) -62.3(6) 
G2 4.315(7) 121.6(1) 0.009(3) 57.9(6) -64.1(6) 
G3 4.024(7) 118.9(1) 0.066(3) -175.9(5) 62.4(6) 
G4 4.336(7) 120.7(1) 0.029(3) 65.1(6) -57.3(6) 
G5 4.279(7) 118.1(1) -0.202(3) 55.1(6) -67.6(6) 
G6 4.157(7) 119.7(1) 0.282(3) -161.8(5) 76.2(7) 
MOF-2 
Molecule Residue D
a
(Å) φb(°) dc(Å) T1
d
(°) T2
e
(°) 
A 
G1 4.262(7) 124.2(2) -0.221(4) 55.4(8) -66.3(8) 
G2 4.112(7) 118.2(2) -0.088(4) -155.1(8) 84(1) 
G3 4.248(7) 118.1(2) 0.285(4) 61.1(8) -61.0(7) 
G4 4.272(7) 122.1(2) -0.166(3) 55.2(8) -66.6(8) 
G5 4.215(7) 119.4(2) -0.136(3) 52.1(9) -72.5(8) 
G6 4.255(7) 114.8(2) 0.327(4) 57.9(8) -65.4(7) 
B 
G1 4.254(7) 117.1(2) 0.104(4) 
-179.1(6) 
53.7(6) 
59.1(9) 
-68.2(6) 
G2 4.315(7) 125.1(2) -0.079(4) 43.9(9) -76.1(8) 
G3 4.024(7) 117.0(2) -0.034(3) 47.4(8) -73.3(7) 
G4 4.336(7) 119.5(1) 0.118(3) -177.4(6) 62.7(8) 
G5 4.279(7) 122.6(2) -0.090(3) 51.0(8) -67.6(7) 
G6 4.157(7) 118.2(2) -0.020(4) 49.7(9) -71.4(7) 
a
 Distance between atoms O4n…O4(n + 1). 
b
 Angles between atoms O4(n-1)…O4n…O4(n+1). 
c 
Deviations (Å) from the least-squares optimum plane of the seven O4n atoms. 
d
 Torsion angle (°) C4n–C5n–C6n–O6n. 
e
 Torsion angle (°) O5n–C5n–C6n–O6n. 
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molecules in MOF-1, while 9 water molecules and 4 methanol molecules are 
cocrystallized in MOF-2 with two methanol molecules taking place at the centers 
of the two α-CD cavities. Hydrogen bonds between the two α-CDs molecules A 
and B, in addition to those among α-CDs, the guest and solvent molecules are 
listed in Table 3.2.4.  
Table 3.2.4 Hydrogen Bonds in MOF-1 and MOF-2. 
MOF-1 
D‒ H A D‒H (Å) H…A (Å) D…A (Å) D‒H…A (°) 
O21B‒H21C O2i 0.82  1.87  2.655(7) 159  
N1‒H1B O34Bii 0.86  2.56  3.195(8) 131  
O1M‒H1M O62Aviii 0.82  1.96  2.638(6) 139  
O3M‒H3M O61Bix 0.82  1.93  2.719(7) 162  
O4M‒H4M O6M 0.82  1.95  2.701(11) 152  
O5M‒H5M O3M 0.82  1.91  2.720(15) 170  
O6M‒H6M O65A 0.82  1.94  2.658(11) 145  
O7M‒H7M O5W 0.82  1.89  2.622(19) 148  
O21A‒H21C O36Aii 0.82  2.12  2.939(6) 174  
O21A‒H21C O46A 0.82  2.45  2.844(5) 111 
O22A‒H22C O31A 0.82  2.43  3.018(6) 129  
O22B‒H22D O32B 0.82  2.49  2.850(6) 108  
O22B‒H22D O36A 0.82  2.44  3.099(5) 138  
O23A‒H23C O1 0.82  2.57  3.182(6) 132  
O23A‒H23C O33A 0.82  2.59  2.897(6) 104  
O23A‒H23C O35Bii 0.82  2.43  3.063(5) 134  
O23B‒H23D O3W 0.82  1.97  2.730(7) 155  
O1W‒H1W1 O35Aiv 1.13  2.55  3.050(7) 105  
O24A‒H24C O33A 0.82  2.02  2.836(6) 170  
O24A‒H24C O43A 0.82  2.46  2.853(5) 111  
O1W‒H2W1 O31Aiv 1.06  2.02  3.070(7) 170  
O25B‒H25C O2Wvii 0.82  1.93  2.678(6) 152  
O26A‒H26C O21Av 0.82  1.97  2.781(5) 168  
O26B‒H26D O1 0.82  2.23  2.833(7) 131  
O26B‒H26D O45B 0.82  2.38  2.795(7) 112  
O2Wviii‒H2W2 O32A 0.84  2.00  2.827(7) 168  
O3Wv‒H1W3 O1W 0.87  2.23  2.936(7) 138  
O3W‒H1W3 O36Aiv 0.87  2.45  2.848(6) 109  
O3W‒H2W3 O21Bii 0.86  2.18  2.814(7) 131  
O4W‒H1W4 O4M 0.87  2.15  2.790(10) 130 
O4W‒H2W4 O66B 0.86  1.89  2.754(9) 179  
O31A‒H31C O31Bii 0.82  2.22  3.035(6) 170  
O31B‒H31D O22B 0.82  2.59  3.033(6) 116 
O5W‒H1W5 O4W 0.87  1.92  2.711(16) 152  
O32A‒H32C O23A 0.82  1.96  2.734(6) 157 
O32B‒H32D O23B 0.82  2.10 2.911(6) 171 
O32B‒H32D O42B 0.82 2.45 2.844(5) 110 
O5W‒H2W5 O63Bii 0.84 2.01 2.848(14) 173 
O33A‒H33C O25Bii 0.82 2.47 2.945(5) 118 
O33A‒H33C O35Bii 0.82 2.53 3.043(5) 122 
O34A‒H34C O24Bii 0.82 2.56 3.044(5) 119 
O34A‒H34C O25Aii 0.82 2.21 2.836(5) 133 
O34B‒H34D O25B 0.82 1.91 2.723(6) 175 
O34B‒H34D O44B 0.82 2.56 2.928(5) 109 
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O35A‒H35C O26A 0.82 2.00 2.799(5) 163 
O35A‒H35C O45A 0.82 2.46 2.827(5) 108 
O35B‒H35D O25B 0.82 2.46 2.810(6) 107 
O35B‒H35D O33Ai 0.82 2.46 3.043(5) 129 
O36A‒H36C O32B 0.82 1.95 2.767(5) 171 
O36B‒H36D O21Bii 0.82 2.03 2.831(6) 166 
O61A‒H61E O5Miii 0.82 1.68 2.445(14) 154 
O61B‒H61F O62Bx 0.82 2.24 2.710(7) 117 
O62A‒H62E O2Miii 0.82 1.92 2.676(8) 153 
O62B‒H62F O52B 0.82 2.43 2.787(7) 107 
O62B‒H62F O61Av 0.82 2.04 2.763(8) 146 
O63A‒H63E O54Bvi 0.82 2.54 3.133(6) 130 
O63A‒H63E O64Bvi 0.82 2.22 2.895(6) 140 
O63B‒H63F O3M 0.82 1.96 2.749(7) 162 
O64B‒H64F O1Mvii 0.82 1.88 2.700(6) 179 
O66A‒H66E O61Biv 0.82 2.47 3.237(8) 157 
O66B‒H66F O7M 0.82 2.01 2.830(11) 177 
Symmetry: i [x,-1+y,z], ii [x,1+y,z] iii [-1+x,y,z], iv [-x,1/2+y,1-z], v  [-x,-1/2+y,1-z], vi  [-x,1/2+y,-z], vii  [1-x,-1/2+y,-z], viii  
[1+x,y,z], ix  [1-x,1/2+y,1-z], x [1-x,-1/2+y,1-z]. 
 
MOF-2 
D‒ H A D‒H (Å) H…A (Å) D…A (Å) D‒H…A (°) 
O1W‒ H1W1 O35Bi 0.84 2.05 2.805(8) 149 
N1 ‒ H1A O2 0.86 2.06 2.690(9) 129 
O1M‒ H1M O4M 0.82 2.18 2.66(2) 117 
O1W‒ H2W1 O2W 0.85 2.48 2.879(7) 109 
O1W‒ H2W1 O33B 0.85 2.49 3.283(8) 156 
O2M‒ H2M O10A 0.84 2.21 2.88(4) 138 
O2W‒ H1W2 O25Aii 0.87 1.97 2.693(8) 140 
O3M‒ H3M O65Bi 0.82 1.87 2.678(8) 170 
O2W‒ H2W2 O23A 0.82 2.24 2.657(7) 112 
O4M‒ H4M O62Aiii 0.82 2.25 2.863(17) 131 
O3W‒ H1W3 O62B 0.84 1.94 2.723(9) 156 
O3W‒ H2W3 O66B 0.84 1.93 2.729(7) 159 
O4W‒ H1W4 O32B 0.87 1.96 2.831(7) 177 
O4W‒ H2W4 O34Biv 0.83 2.07 2.896(7) 173 
O5W‒ H1W5 O9Wv 0.85 2.17 2.939(12) 150 
O5W‒ H2W5 O61Bvi 0.85 2.13 2.844(10) 141 
O5W‒ H2W5 O63Avi 0.85 2.37 2.763(9) 108 
O6W‒ H1W6 O53A 0.84 2.10 2.942(8) 176 
O6W‒ H2W6 O7W 0.88 1.99 2.867(10) 177 
O7W‒ H1W7 O52Bvii 0.89 2.22 2.952(8) 139 
O7W‒ H2W7 O6W 0.85 2.44 2.867(10) 112 
O8W‒ H1W8 O64Aii 0.86 2.33 2.914(10) 126 
O8W‒ H2W8 O9Wviii 0.84 2.21 2.853(13) 133 
O9W‒ H1W9 O65Aii 0.89 2.32 3.028(14) 137 
O9W‒ H2W9 O56A 0.85 2.25 3.095(11) 172 
O21A‒ H21C O1i 0.82 1.88 2.618(7) 149 
O21A‒ H21C O46A 0.82 2.57 2.863(7) 103 
O21B‒ H21D O2 0.82 2.30 3.117(7) 177 
O22A‒ H22C O31A 0.82 1.99 2.799(7) 167 
O22A‒ H22C O41A 0.82 2.39 2.808(8) 112 
O22B‒ H22D O32B 0.82 2.52 2.894(7) 109 
O22B‒ H22D O36A 0.82 2.38 3.194(7) 170 
O23A‒ H23C O2W 0.82 2.38 2.657(7) 101 
O23A‒ H23C O33A 0.82 2.54 2.885(7) 106 
O23A‒ H23C O35Bi 0.82 2.51 3.277(7) 155 
O23B‒ H23D O32B 0.82 2.19 2.852(6) 137 
O23B‒ H23D O42B 0.82 2.50 2.804(7) 103 
O24A‒ H24C O33A 0.82 2.14 2.949(7) 169 
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O24A‒ H24C O43A 0.82 2.42 2.807(7) 110 
O24B‒ H24D O22Bvii 0.82 1.88 2.670(7) 162 
O25A‒ H25C O34A 0.82 2.05 2.866(7) 172 
O25A‒ H25C O44A 0.82 2.44 2.830(7) 110 
O25B‒ H25D O33Aii 0.82 2.42 3.016(7) 130 
O25B‒ H25D O21Bix 0.82 2.08 2.671(7) 129 
O26A‒ H26C O35Aii 0.82 2.03 2.843(7) 170 
O26A‒ H26C O45A 0.82 2.41 2.818(7) 111 
O31A‒ H31C O2i 0.82 2.07 2.662(7) 129 
O31B‒ H31D O1 0.82 2.56 3.028(7) 118 
O31B‒ H31D O21Aii 0.82 2.11 2.875(7) 156 
O32A‒ H32C O23A 0.82 1.96 2.765(7) 166 
O32B‒ H32D O26A 0.82 2.52 2.955(7) 115 
O32B‒ H32D O36A 0.82 2.05 2.835(7) 161 
O33A‒ H33C O23A 0.82 2.60 2.885(7) 102 
O33A‒ H33C O35Bi 0.82 2.21 3.013(7) 166 
O33B‒ H33D O24B 0.82 2.09 2.777(7) 142 
O34A‒ H34C O34Bi 0.82 2.06 2.849(7) 160 
O34B‒ H34D O25B 0.82 1.94 2.735(6) 162 
O34B‒ H34D O44B 0.82 2.56 2.922(7) 108 
O35A‒ H35C O33Bi 0.82 2.11 2.873(7) 155 
O35B‒ H35X O26Bii 0.82 2.21 2.985(7) 158 
O35B‒ H35X O45Bii 0.82 2.48 2.829(7) 107 
O36A‒ H36C O1 0.82 1.92 2.693(7) 156 
O36B‒ H36D O2i 0.82 2.29 3.031(7) 151 
O36B‒ H36D O21Bi 0.82 2.54 2.891(7) 107 
O61A‒ H61E O63Ax 0.82 1.97 2.754(7) 159 
O62A‒ H62E O10Ai 0.86 2.50 3.240(20) 145 
O62B‒ H62F O8Wiv 0.82 1.87 2.660(10) 160 
O63A‒ H63E O5Wxi 0.82 1.95 2.763(9) 172 
O63B‒ H63F O3M 0.82 1.97 2.740(8) 157 
O64A‒ H64E O66Axii 0.82 1.90 2.712(7) 169 
O64B‒ H64F O54B 0.82 2.44 2.824(7) 110 
O64B‒ H64F O66Avii 0.82 2.13 2.863(8) 150 
O65A‒ H65E O3Wxiii 0.82 1.98 2.759(7) 159 
O65B‒ H65F O51Avii 0.82 2.59 3.145(7) 126 
O65B‒ H65F O61Avii 0.82 2.02 2.760(7) 150 
O66A‒ H66E O63Biv 0.82 1.95 2.727(7) 157 
O66B‒ H66F O5W 0.82 1.95 2.764(8) 176 
Symmetry: i [-1+x,y,z],  ii [1+x,y,z], iii [1+x,y,1+z], iv[1-x,-1/2+y,1-z], v [x,y,1+z], vi [-x,-1/2+y,1-z], vii[1-x,1/2+y,1-z], viii [1-
x,1/2+y,-z], ix [2-x,1/2+y,1-z],   x [-x,-1/2+y,-z], xi [ -x,1/2+y,1-z], xii [ -x,1/2+y,-z], xiii [-1+x,y,-1+z ]. 
 
The crystal structures of MOF-1 and MOF-2 reveal that K
+
 cations not only 
assist in the assembly of (α-CD)2 boxes, but they also serve to link these boxes 
together in a one-dimensional array extended throughout crystal parallel to b-axis 
in MOF-1 and to a-axis in MOF-2. Each K
+
 cation is involved in the assembly of 
pairs of α-CD repeating motifs by coordination to the secondary faces of adjacent 
α-CD tori, through their secondary hydroxyl groups. At this level of structure, 
significant differences between the two MOFs appears in the nature of ligands that 
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coordinate the K
+
 cation and in the coordination number of K
+
 cation [Figure 
3.2.7]. 
In MOF-1, K
+
 links four contiguous α-CD molecules by coordination to their 
secondary faces and one oxygen atom comes from the carboxylate group of 
mABA, K
+…O bond lengths range from 2.697(5)  to 3.273(4) Å, resulting in an 
overall coordination number of eight around each K
+
 ion. In MOF-2, K
+
 links, 
also, four contiguous α-CD molecules by coordination to their secondary faces and 
    
a                                                         b 
Figure 3.2.7 Potassium coordination (a) in MOF-1 and (b) in MOF-2. 
one oxygen atom of water molecules, with K
+…O bond lengths ranging from 
2.662(5)-2.918(5) Å, resulting in an overall coordination number of seven around 
each K
+
 ion.  The majority of K
+…O bonds lengths, in both MOFs, are longer than 
the sum of the ionic radii of K and O (2.66 Å) [Table 3.2.5].  
The anionic form of mABA and oABA is observed in the complex with α-
CD.KOH where it plays the role of counterion for the potassium cation. No extra 
electron density peaks are  observed in difference Fourier maps neither close to the 
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Table 3.2.5 Potassium coordination in MOF-1 and MOF-2. 
 
COO
-
 nor the NH2 groups that could account for an extra H atom. Deprotonation of 
the carboxylic function is further established by similar values for the two C-O 
bond lengths: 1.273(8) and 1.232(8) Ǻ in mABA, 1.277(9) and 1.270(9) Ǻ in 
oABA. Both mABA and oABA are planar entities with non-hydrogen atoms lie in 
a plane within 0.0469 and 0.0930 Å, respectively. The mABA
-
 anion plays role as 
one of the eight ligands that bind the potassium cation through the -COO
-
 group 
(K
+…O- = 2.893(5) Å). In contrast, this is not observed in the case of oABA- anion. 
The angles between the aromatic rings of the guest ions and the two O4n plans are 
10.68(3)° and 4.61(3)° in MOF-1, 4.70(9)° and 5.31(9)° in MOF-2 [Figure 3.2.6].  
The overall stacking arrangement of the MOFs in the crystal structure is in 
head-to-head monomers linked together by K
+
 cations forming chains extended 
along the b-direction in MOF-1, and the a-direction in MOF-2, which are stacked 
in a zipper-like fashion in these directions. This leads to an extensive hydrogen 
bonding, not only between the secondary hydroxyls groups of both α-CD rings 
MOF-1 MOF-2 
M‒L Bond length (Ǻ) M‒L Bond length (Ǻ) 
K1‒O2 2.893(6) K1‒O4W 2.897(7) 
K1‒O24B 2.822(4) K1‒O22A 2.861(5) 
K1‒O22A 2.840(5) K1‒O23B 2.732(5) 
K1‒O25A 2.745(4) K1‒O26A 2.721(6) 
K1‒O26B 3.028(5) K1‒O26B 2.719(5) 
K1‒O32A 2.697(5) K1‒O32A 2.662(5) 
K1‒O36B 2.703(5) K1‒O36B 2.918(5) 
K1‒O33B 3.273(4)   
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forming the dimers, but also including the primary hydroxyls groups of the α-CD 
rings and the solvent molecules. This gives the cavities a slightly elliptical shape 
[Figure 3.2.8]. 
3.3 Conclusion  
The interaction between potassium cations and α-CD have been established 
and well characterized in the crystalline state. The structure shows 3D MOFs and 
α-CD adopts a cage crystal structure packing stabilized, mainly, by coordinating 
the potassium cation through the ‒OCCO‒ motifs, in addition to intermolecular 
and intramolecular hydrogen bondings. A new morph of α-CD belonging to the 
tube crystal structure packing form has been accidentally established during the 
attempt to produce an inclusion complex with mABA and oABA. This new morph 
has a potential application in the field of gas storage and molecular absorption. 
Although present during crystallization, the “guest” mABA or oABA is not present 
in the crystal. Its presence is however essential to obtain this polymorphic form. A 
new technique was found to prepare a drug carrier based on the cyclodextrins by 
relying on their ability to form MOFs with alkali metals cations and possession of 
a hydrophobic cavity to receive the drug molecule inside. Two MOFs were 
prepared by this technique between α-CD and K+mABA- and K+oABA- showing 
a1D MOFs where K+ cations assist in the assembly of two α-CD molecules to 
form a box containing a guest inside the cavity.   
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(a) 
      
(b) 
      
(c) 
Figure 3.2.8 Drawing of the packing of the MOF-1 (left) and MOF-2 (right), viewed along a 
axis (a), b axis (b) and c axis (c). 
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3.4 Experimental 
3.4.1 Crystallization 
Crystals of α-CD-KOH MOF were prepared by dissolving α-CD and KOH in 
water in 1:8 stoichiometry. The solution was stirred and heated about 60°C. Then 1 
ml of this solution was taken in a 3ml tube and this in turn was placed in a 100 ml 
flask containing methanol. The slow diffusion of methanol vapor in aqueous 
solution causes a decrease in the solubility of the substances in the mixture of 
water / methanol and thus formation of crystals. Colorless crystals, parallelepiped 
prism shaped, suitable for X-ray data collection were obtained after one week. 
An attempt, also, has been performed to prepare inclusion complex between 
α-CD and oABA and mABA, by dissolving α-CD (0.1mmol) in water (2.5 mL) at 
65°C and oABA or mABA (0.1mmol) in ethanol (2.5 mL) at 65°C. Both solutions 
were mixed and stirred at 65°C for 6 hours. Then the mixture was stored at room 
temperature. Colorless crystals, hexagonal prism shaped, suitable for X-ray data 
collection were obtained by slow evaporation after one week.  
Crystals of complexes between α-CD and K+oABA-  and K+mABA-  salts  
were prepared by dissolving oABA or mABA and KOH in water and then adding 
α-CD to the solution. 1 ml of this solution was taken in a 3ml tube and this in turn 
was placed in a 100 ml flask containing methanol. Colorless crystals, 
parallelepiped prism shaped, suitable for X-ray data collection were obtained in a 
few days.  
3.4.2 X-ray diffraction experiment. 
X-ray diffraction experiments were carried out at low temperature (~150° K) 
on an Oxford Gemini R Ultra using Mo Kα radiation (λ= 0.7107 Å) operating at 50 
kV, 40 mA in case of a-CD-KOH, MOF-1 and MOF-2, and using Cu Kα radiation 
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(λ= 1.5418 Å) in case of new polymorph of α-CD. Data reduction was carried out 
with the CrysAlisPro program [43].  
The structures were determined by direct method using SIR2011 package [44] 
and refined using full-matrix least-squares based on F
2
 with the program SHELX 
[45]. The refinement procedures converged to R1= 0.0395 for I > 2sigma(I) and 
0.0499 for all data in α-CD-KOH, 0.0774 for I > 2sigma(I) and 0.0873 for all 
data in α-CD new polymorph, 0.0733 for I > 2sigma(I) and 0.0782 for all data in 
MOF-1 and 0.0896 for I > 2sigma(I) and 0.1017 for all data in MOF-2. Water and 
methanol molecules were located in difference Fourier maps. All non-hydrogen 
atoms were anisotropically refined. Secondary hydroxyl groups were refined with 
two alternate conformations. Hydrogen atoms were calculated at ideal positions 
and refined using a riding model except those attached to some hydroxyl groups 
and on the water molecules that were located in difference Fourier maps. Selected 
crystal data collection and refinement details are listed in Table 3.4.1. 
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Table 3.4.1 Crystallographic data. 
Crystallographic data α-CD-KOH 
α-CD new 
polymorph  
MOF-1
 
MOF-2
 
Chemical formula 
C36H60O30,K2CO3, 
CH3OH, 5H2O 
4C36H60O30, nH2O 
2C36H60O30,KC7H6NO2, 
7CH3OH, 5H2O 
2C36H60O30,KC7H6NO2, 
4CH3OH, 10H2O 
Temperature (K) 150(2) 150(2) 150(2) 150(2) 
Wavelength (Å) Mo Kα λ= 0.7107 Cu Kα λ= 1.5418 Mo Kα λ= 0.7107 Mo Kα λ= 0.7107  
Crystal system Orthorhombic Hexagonal Monoclinic Monoclinic 
Space group P212121 R3 P21 P21 
a (Å) 13.1136(3) 23.6696(4) 16.4499(5) 14.1031(6) 
b (Å) 13.9866(4) 23.6696(4) 14.1657(4) 23.3959(8) 
c (Å) 28.7054(8) 109.0704(15) 23.5031(6) 16.6293(7) 
α (°) 90.00 90.00 90.0 90.0 
β (°) 90.00 90.00 93.206(2) 95.139(4) 
γ (°) 90.00 120.00 90.0 90.0 
Volume (Å
3
) 5265.0(2) 52920(2) 5468.2(3) 5464.8(4) 
Z 4 36 2 2 
Crystal description Parallelepiped Hexagonal prism Prism Prism 
Theta range for data 
collection (°) 
3.37 - 29.23 2.69 - 67.57 3.16 - 28.16 3.24 - 29.20 
Limiting indices 
−15 ≤ h ≤ 15 
−16 ≤ k ≤ 13 
−30 ≤ l ≤ 34 
−28 ≤ h ≤ 24 
−24 ≤ k ≤ 25 
−110≤ l ≤ 129 
−15 ≤ h ≤ 15 
−16 ≤ k ≤ 13 
−30 ≤  l ≤ 34 
−13 ≤ h ≤ 19 
−31 ≤ k ≤ 29 
−21 ≤  l ≤ 22 
Reflections 
collected/unique 
9137 / 7440 34303/29042 16961/15713 17413/14917 
R (int) 0.0264 0.0302 0.0401 0.0798 
Data/restraints/paramet
ers 
9137/2/732 34303/1/3097 16961/48/1457 17413/65/1454 
Goodness-of-fit (S) on 
F
2
 
0.971 1.047 1.076 1.090 
Refinement method 
Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
Final R indices [I > 
2sigma(I)] 
0.0395 0.0774 0.0733 0.0896 
Final R indices (all 
data) 
0.0499 0.0873 0.0782 0.1017 
Largest difference peak 
and hole (e/Å
3
) 
0.445, -0.373 1.178, -0.754 1.023, -0.922 1.181, -0.519 
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Chapter 4 
Determination of the structure and the absolute configuration of 
Aegelinol and 1,10-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-
1,2,3,4-tetrahydroisoquinoline) hydrochloride  by using X-ray 
diffraction technique 
 
Abstract 
The absolute configuration and crystal structure of three stereoisomers of 
1,10-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-
tetrahydroisoquinoline) hydrochloride, after resolution by semi-preparative chiral 
HPLC, and aegelinol, a pyranocoumarin isolated from Ferulago asparagifolia 
Boiss (Apiaceae), has been determined by crystallography. Absolute configuration 
of the first mentioned compounds were obtained directly by Flack parameter, while 
the crystal structure of the inclusion complex of aegelinol in β-cyclodextrin 
allowed unambiguous determination of the absolute configuration of the 
stereogenic center of aegelinol. 
4.1 Introduction 
4.1.1  Absolute configuration 
An absolute configuration in stereochemistry is the spatial arrangement of the 
atoms of a chiral molecular entity or group and when the absolute configuration is 
obtained the assignment of R or S is based on the Cahn-Ingold-Prelog priority rules 
[1].  
Absolute configuration of synthetic chiral molecules can often be deduced 
from knowledge of reaction mechanisms in organic chemistry applied to well-
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characterized transformations from starting materials of known absolute 
configuration to the final products. Optical rotation and circular dichroism can also 
be used to predict absolute configuration, usually based on rules for the sign of the 
rotation angle or circular dichroism bands. Nuclear magnetic resonance (NMR) is 
blind to chirality, but ancillary methods for deducing absolute configuration using 
chiral shift reagents or chemical derivatives have been devised. However, 
whenever methods such as organic reaction mechanisms, optical rotation, circular 
dichroism or NMR are relied upon fully over time, exceptions necessarily arise that 
result in erroneous predictions. Conversely, X-ray crystallography, with its many 
technical improvements in recent years, has become the recognized standard for 
the a priori determination of the absolute configuration of chiral molecules. 
All enantiomerically pure chiral molecules crystallize in one of the 65 
Sohncke Groups (Chiral Space Groups: these 65 space groups contain only 
rotation or screw axes. They are space group numbers: 1, 3-5, 16-24, 75-80, 89-
98, 143-146, 149-155, 168-173, 177-182, 195-199 and 207-214). Rigorous 
differentiation of enantiomers by the X-ray diffraction method is now possible 
through several ways. For example, a comparison of the intensities of Bijvoet pairs 
or of the R factors for the two possible structures can suggest the correct absolute 
structure. One of the more powerful and simple approaches is using the Flack 
parameter x(u), because this single parameter clearly indicates the absolute 
structure [2-3]. The processes used to decide the absolute structure by Flack 
parameter use the anomalous dispersion effect (anomalous scattering effect).  
The scattering of X-rays from electrons is called Thomson scattering. It occurs 
because the electron oscillates in the electric field of the incoming X-ray beam and 
an oscillating electric charge radiates electromagnetic waves. Thus, X-rays are 
radiated from the electron at the same frequency as the primary beam. However, 
most electrons radiate π radians (180◦) out of phase with the incoming beam, as 
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shown by a mathematical model of the process. The motion of an electron is 
heavily damped when the X-ray frequency is close to the electron resonance 
frequency; this occurs near an absorption edge of the atom, this led to changing the 
relative phase of the radiated X-rays to π/2 (90°) and giving rise to the 
phenomenon of anomalous (resonant) scattering. If anomalous scattering takes 
place, the atomic scattering factor*(Fig 4.1.1) is altered to take this into account. 
Only some of the electrons in the atom are affected and they will scatter the X-rays 
roughly π/2 out of phase with the incident beam. Electrons scattering exactly π/2 
out of phase are represented mathematically by an imaginary component of the 
scattering factor and they cease to contribute to the real part.[4] 
However, atomic scattering factors have imaginary parts due to the anomalous 
dispersion effect, and Friedel's law is broken by this effect. As it has been 
mentioned above, the anomalous dispersion occurs when a wavelength λ is 
selected that is near the absorption edge of an atom creates a partial ionization 
process. Some new X-ray radiation is generated from the inner electron shells of 
the atoms. Thus the atomic scattering factor can therefore be best described as a 
complex number:       
fj = fj,o + Δfj
'
 + i.Δfj
"
 
Where:  
 fj : is the atomic scattering factor. 
 fj,o : is a function of diffraction angle θ  and equal to the number of electrons  
in the j
th
 atom at θ = 0.      
 Δfj
′
  and  Δfj
″
 : are an atom type and λ dependent. 
 i = √   , the imaginary unit. 
* An atom that can be considered as a set of Z electrons (its atomic number) can be expected to scatter Z 
times that which an electron does. An atom scatters Z times only in the direction of the incident beam, 
decreasing with the increasing of the θ angle (the angle between the incident radiation and the direction 
where we measure the scattering). We give the name atomic scattering factor to the ratio between the 
amplitude scattered by an atom and a single electron.  
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Fig. 4.1.1 Dependence of atomic scattering factors on diffraction angle θ. 
 
 We can conclude from the previous discussion that if atomic scattering 
factors did not have imaginary parts, the Friedel pairs would have exactly the same 
amplitudes (Friedel's law) i.e., the scattering intensity |F(h k l)|
2
 from crystal plane 
(h k l) is equal to |F(-h -k -l)|
2
 from the opposite crystal plane (-h -k -l). In this case 
the intensity is given: 
I(hkl) = |F(h k l)|2 
In the case of the anomalous dispersion, the atomic scattering factors have 
imaginary parts; the Friedel pairs wouldn’t have exactly the same amplitudes: 
|F(h k l)|2   ≠  |F(-h -k -l)|2 
Then the Flack parameter can be calculated during the structural refinement using 
the equation given below: 
I(hkl)=(1-x) |F(hkl)|2 + x|F(-h-k-l)|2 
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Where: 
 x : is the Flack parameter usually found to be between 0 and 1. 
 I(hkl) : is the scaled observed intensity at the position hkl. 
 F(hkl): calculated structure factor: 
It can be expressed in terms of the contents of a single unit cell as: 
 (   )  ∑  
 
   
    (           ) 
 N: is the number of atoms in the unit cell. 
 fj : is the atomic scattering factor of j
th
 atom. 
 i = √   , the imaginary unit. 
 xj, yj and zj are the fractional coordinates that give the position of the j
th
 atom. 
If the x value is near 0, with a small standard uncertainty (u), the absolute structure 
given by the structure refinement is likely correct, and if the value is near 1, then 
the inverted structure is likely correct. If the value is near 0.5, the crystal may be 
racemic or twinned. The technique is most effective when the crystal contains both 
lighter and heavier atoms. Light atoms usually show only a small anomalous 
dispersion effect. 
There are conditions under which one may say that the absolute structure of 
the crystal has been determined satisfactorily:  
 Firstly one wants to know whether the absolute configuration 
determination is sufficiently precise by looking to see whether the 
standard uncertainty u of the Flack parameter x(u) is sufficiently small: in 
general u should be less than 0.04 but this value may be relaxed to 0.10 
for a compound proven by other means to be enantiomerically pure. 
 Secondly the value of the Flack parameter itself should be close to zero 
within a region of three standard uncertainties i.e. u < 0.04 (or u < 0.10 
for a chemically proven enantiomeric excess of 100%) and |x| < 3u [5]. 
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However, the absolute configuration could not be determined by anomalous 
dispersion effects in the diffraction measurement on the crystal due to the absence 
of atoms heavier than oxygen. This gives rise to standard uncertainties on the Flack 
parameter which is too large for reliable absolute configuration determination [5].  
Options for the absolute structure determination of light atom compounds are still 
possible: 
1) Recently Rob Hooft came up with a new statistical method based on Bayesian 
statistics (Statistical analysis of Bijvoet pair differences). This method gives 
access to a Hooft’s parameter which is very similar to Flack parameter (Hooft, 
R.W.W.; Straver, L.H.; Spek, A.L. Determination of absolute structure using 
Bayesian statistics on Bijvoet differences. J. Appl. Cryst. 2008, 41, 96–
103.)[10]. 
2) Preparing a salt from the compound (e.g. add HBr in case of tertiary N). 
3) Co-crystallize with heavy atom compounds (e.g. CBr4). 
4) Co-crystallize with compound with known absolute configuration (e.g. CDs). 
In many cases, thus, it may be necessary to perform a derivatization of the 
compound to get a crystalline product. If a chiral reagent is used for this purpose, a 
second stereogenic center of known absolute configuration is introduced and the 
X-ray structure obtained is then unambiguous and gives the absolute configuration 
of the first compound. This approach is classical when salts can be formed, which 
is not the case for some molecules. 
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4.1.2  1,10-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl -1,2,3,4-
tetrahydroisoquinoline)* 
Synthesis and purification of compounds were performed by the group of 
Prof. J.-F. Liégeois at ULg. 
Small conductance Ca
2+
-activated K
+
 (SK) channels play a role in modulating the 
firing rate and the firing pattern of neurons [6]. A blockade of these targets could 
be useful for the treatment of cognitive dysfunction, neuronal hyperexcitability or 
dopamine related disorders [7]. Currently, available blockers are not suitable 
pharmacological tools being either peptides or quaternized small molecules [8]. 
Therefore, from N-methyl-laudanosine a medium potency blocking compound 
with a quick reversibility [9], it was developed bis-isoquinolinium derivatives with 
an increased affinity and activity [10]. 
The mixture of stereoisomers of 1,10-(propane-1,3-diyl)-bis-(6,7-dimethoxy-
2-methyl-1,2,3,4-tetrahydroisoquinoline) (Fig 4.1.2) was obtained by reduction of 
the corresponding bis-isoquinolinium analogue [10] with sodium borohydride 
under nitrogen atmosphere in methanol. Then, each stereoisomer was isolated by 
resolution of the bis-tetrahydroisoquinoline mixture by semi-preparative chiral 
HPLC using a Chiralcel
®
 OD-H column and a mixture of 2-propanol (80)/hexane 
(20) containing 0.05% diethylamine at a flow rate of 1 mL/min (Fig. 4.1.3). In 
these conditions, the retention time for the first eluted enantiomer (E1), the meso 
and the second enantiomer (E2) are ~ 7 min, 10 min and 23 min respectively. 
Finally, the three compounds are converted into their hydrochloride salt which 
crystallized in a mixture of methanol/diethyl ether. The hydrochloride forms of 
both enantiomers E1 and E2 were solubilized in MeOH for specific rotation 
measurements. The  [ ] 
    of the first eluted enantiomer, E1, and the second eluted  
* Part of this work has been published (European Journal of Medicinal Chemistry 2010, 45, 3240-3244) 
A reprint of this paper is given as supplementary material.  
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enantiomer, E2, are +34.8° and -34.5° respectively. 
 
Fig.4.1.2 Chemical structure of 1,10-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-
tetrahydroisoquinoline) dihydrochloride. Numbering of selected atoms is presented. 
 
 
Fig.4.1.3 Resolution of a diastereoisomeric mixture of 1,10-(propane-1,3-diyl)-bis-(6,7 
dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline) using a Chiralcel
®
 OD-H column and a 
mixture of 2-propanol (80)/hexane(20) containing 0.05% diethylamine at a flow rate of 1 
mL/min. 
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4.1.3  Aegelinol* 
Aegelinol [11] is a pyranocoumarin that was isolated from Ferulago 
asparagifolia Boiss (Apiaceae), a species growing in Turkey [11]. Aegelinol has 
also been reported as a minor lactonic constituent of Aegle marmelos [12]. Three 
abundant pyranocoumarins (grandivittin (2), agasyllin (3) and aegelinol benzoate 
(4)) (Fig. 4.1.4) were also isolated from the roots of Ferulago campestris collected 
in Sicily and aegelinol (1), their hydrolysis product, and agasyllin (3) showed a 
significant antibacterial effect against Gram-negative and Gram-positive bacteria 
[13]. 
 Fig. 4.1.4 The chemical structure and numbering scheme of pyranocoumarins. 
The absolute configuration of (1) could not be determined because NMR 
spectral data of  and  epimers do not significantly differ. Optical rotation 
measurements however suggest an  configuration for the compound [11]. 
Compounds (2-4) are ester derivatives of aegelinol (1), whose absolute 
configuration at C-2’ was also not clear. Abyshev et al. [14] reported an (S) C-2’ 
absolute configuration, although they cited the degradative determination of the 
absolute configuration performed by Lemmich [15]. On the other hand, 
Erdelmeyer et al. [16] indicated an (R) C-2’ configuration. In both cases, the 
reported optical rotation of the compound was negative. Hydrolysis of the three 
esters gives the same compound (1) with a negative optical rotation. Consequently, 
* Part of this work has been published (Crystals 2012, 2, 1441-1454). A reprint of this paper is given as 
supplementary material.  
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Basile et al [17] decided to determinate the absolute stereochemistry by means 
of Mosher’s and Horeau’s (indirect) methods [18-20] and assigned from their 
NMR data an R configuration for (1) and its esters (2-4).  
To circumvent this limit, we decided to co-crystallize aegelinol (1) with -
cyclodextrin. In principle, formation of such an inclusion complex with a host of 
known chirality (-cyclodextrin consists of seven optically active D-glucose units) 
should allow direct determination of the absolute configuration of the guest 
(aegelinol). Indeed, in principle, cyclodextrins form diastereoisomers by including 
optically active guests within their cavity and should be excellent reagents for the 
resolution of racemic compounds (and subsequent determination of their absolute 
configuration). In practice, possibly due to their round and symmetrical structure, 
only low optical resolution is achieved [21]. As a matter of fact, only a limited 
number of crystal structures of inclusion complexes of cyclodextrins with chiral 
guests are available in the Cambridge Structure DataBank (CSD), among which 
permethylated -cyclodextrin binding S- and R-mandelic acid (CECMAY10 and 
CECMEC10- respectively) [22] or R- and S-isomers of flurbiprofen and S-
ibuprofen (COYXAP10, COYXET20 [23] and RONWOG [24] respectively) 
included within the cavity of permethylated β-cyclodextrin. Selected examples of 
crystal structures of cyclodextrin’s inclusion complexes with different chiral 
molecules are presented in Table 4.1.1, [25-43]. 
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Table 4.1.1. Selected examples of crystal structures of cyclodextrin’s inclusion complexes with 
different chiral molecules available in the Cambridge Structure DataBank (CSD). 
CSD (refcode) Structure name reference 
CECMAY10 Permethylated-α-cyclodextrin    (S)-madelic acid [22] 
CECMEC10 Permethylated-α-cyclodextrin    (R)-madelic acid [22] 
COYXAP10 Permethylated-α-cyclodextrin    (R)-flurbiprofen [23] 
COYXET20 Permethylated-α-cyclodextrin    (S)-flurbiprofen [23] 
RONWOG Permethylated-α-cyclodextrin    (S)-ibuprofen [24] 
QOYLEV 
hexakis(2,3,6-Tri-O-methyl)-α-cyclodextrin (R)-1,7-
dioxaspiro(5.5)undecane clathrate 
[25] 
QOYLIZ 
heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin (S)-1,7-
dioxaspiro(5.5)undecane clathrate hydrate 
[25] 
RACVIA 
hexakis(2,3,6-Tri-O-methyl)-α-cyclodextrin (S)-1,7-
dioxaspiro(5.5)undecane clathrate hexahydrate 
[26] 
RACVIA01 
hexakis(2,3,6-tri-O-methyl) α-cyclodextrin (R)-(-)-1,7-
dioxaspiro[5.5]undecane clathrate hydrate 
[27] 
AGAZIR 
β-Cyclodextrin N-acetyl-L-phenylalanine clathrate 
dodecahydrate 
[28] 
AGAZUD β-Cyclodextrin N-acetyl-D-phenylalanine clathrate hydrate [28] 
BEGWEQ 
bis(β-Cyclodextrin) ((3S-trans)-3-((1,3-benzodioxol-5-
yloxy)methyl)-4-(4-fluorophenyl)piperidine) clathrate hydrate 
[29] 
BIJHOR α-Cyclodextrin 1-phenylethanol tetrahydrate clathrate [30] 
CETKUI 
heptakis(2,3,6-Tri-O-methyl)-β-cyclodextrin (-)-(R)-methyl-5-
(p-tolyl)imidazolidine-2,4-dione clathrate 
[31] 
DOCVUM04 
bis(β-Cyclodextrin) bis(N-acetyl-L-phenylalanine methyl 
ester) clathrate hydrate 
[32] 
 
VOQDOU 
bis(β-Cyclodextrin) bis(N-acetyl-L-phenylalanine amide) 
clathrate hydrate 
[32] 
VOQDUA 
bis(β-Cyclodextrin) bis(N-acetyl-p-methoxy-L-phenylalanine 
methyl ester) clathrate hydrate 
[33] 
DOCVUM06 
bis(β-Cyclodextrin) bis(N-acetyl-L-phenylalanine methyl 
ester) clathrate hydrate 
[34] 
EKOGOA 
Per-O-methyl-β-cyclodextrin (S)-1-(p-bromophenyl) ethanol 
clathrate 
[35] 
EKOGOA01 
Per-O-methyl-β-cyclodextrin (S)-1-(p-bromophenyl) ethanol 
clathrate 
[36] 
YIRZOP 
hexakis(2,3,6-Tri-O-methyl)-α-cyclodextrin (S)-1-
phenylethanol clathrate 
[37] 
ZIFQOU (S)-Naproxen heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin [38] 
GETPAW β-Cyclodextrin (R)-(-)-fenoprofen clathrate hydrate [39] 
JEJWOK 
hexakis(2,3,6-Tri-O-methyl)-α-cyclodextrin (R)-1-
phenylethanol monohydrate clathrate 
[40] 
JEJXAX 
hexakis(2,3,6-Tri-O-methyl)-α-cyclodextrin (S)-1-
phenylethanol monohydrate clathrate 
[40] 
PACJEJ 
3,5-Dihydroxy-4-(3-hydroxy-4 methoxydihydrocinnamoyl) 
phenyl)-2-O-(a-L-rhamnopyranosyl)-b-D-glucopyranoside β-
cyclodextrin clathrate hydrate 
[41] 
POVSIC β-Cyclodextrin trans-cyclohexane-1,4-diol hydrate [42] 
TUSHEV bis(α-cyclodextrin) (R)-camphor clathrate hydrate [43] 
TUSHIZ bis(α-cyclodextrin) (S)-camphor clathrate tetradecahydrate [43] 
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4.2 Aim of this chapter 
In the present work, we report on our efforts to determine, by X-ray 
crystallography, the structure and the absolute configuration of 1,10-(propane-1,3-
diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline) and aegelinol. 
And we show that crystallization of an inclusion complex of aegelinol in - 
cyclodextrin solved the problem of the inaccurate absolute configuration 
determination by X-ray anomalous dispersion effects in light atom compounds. 
4.3 Results and Discussion 
4.3.1 Crystal structure of 1,1'-(propane-1,3-diyl)-bis-(6,7-dimethoxy-
2-methyl-1,2,3,4-tetrahydroisoquinolinum)   
The crystal structures of the three stereoisomers, E1, E2, and meso of the 1,1'-
(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinum) 
hydrochloride salts (Fig.4.3.1), correspond to the hydrochloride salts of the 
isoquinoliniums.  
                  
 
Fig. 4.3.1 Crystal structure conformation (ORTEP thermal motion diagram drawn at 50% 
probability) of E1 (left) and meso (right). Structure E2 (mirror image of E1) is not presented. H 
atoms have been omitted for clarity. Only two water molecules are present in the asymmetric 
unit of the meso structure. 
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Main crystal data are summarized in Table 4.3.1. Interestingly, the meso 
structure co-crystallized with 5 water molecules. Stereochemistry of C10 and C20 
has been unambiguously established as underlined by the Flack parameters [2] 
reported in Table 4.3.1: C10 (S)/C20 (S) for E1, C10 (R)/C20 (R) for E2, C10 
(R)/C20 (S) and C10 (S)/C20 (R) for meso.  
Table 4.3.1. Main statistics on data quality and refinement for the crystal structures of 1,1'-
(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinum) 
Crystallographic data E1 Meso E2 
Formula C27H38N2O4.2 HCl 
C27H38N2O4.2 
HCl.5H2O 
C27H38N2O4.2 HCl 
Mol. Wt. 527.51 617.59 527.51 
Dimensions (mm
3
) 0.43 0.37  0.07 0.4  0.2  0.05 0.42 0.12  0.04 
Crystal system monoclinic monoclinic monoclinic 
Space group P 21 P 21/c P 21 
a (Å) 11.379(1) 11.745(1) 11.368(1) 
b (Å) 8.382(1) 27.328(3) 8.365(1) 
c (Å) 15.974(3) 11.337(1) 15.974(2) 
 (°) 90.00 90.00 90.00 
 (°) 102.26(1) 115.41(1) 102.24(1) 
 (°) 90.00 90.00 90.00 
V (Å
3
) 1487.5(4) 3286.8(5) 1484.5(3) 
Z 2 4 2 
Dcalc (gcm
-3
) 1.178 1.832 1.178 
CuK (mm
-1
) 0.250 1.248 0.251 
Abs. correction multi-scan multi-scan multi-scan 
F(000) 564 1328 564 
Meas. reflections 11,920 30,600 12,353 
Unique reflections 5223 7139 5205 
Rint 0.0244 0.0303 0.0360 
Obs. refl. (I0>2(I0)) 4735 4663 3637 
Parameters refined 316 361 316 
Goof on F
2 
1.057 1.003 0.906 
R1 0.0415 0.0438 0.0437 
wR2 (I0 > 2σ(I0)) 0.1023 0.1041 0.0825 
wR2(all data) 0.1040 0.1124 0.0874 
Flack parameter 0.00(5) - -0.01(6) 
Fraction of Friedle pairs 0.853 - 0.849 
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Bond lengths and valence angles are similar (within experimental errors) in all 
three compounds and in agreement with geometries observed in similar structures 
reported in the literature (e.g. structure of alkaloid (±) carnegine, 1,2-Dimethyl-6,7-
dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, CSD refcode KORWOD 
(Fig. 4.3.2) ) [44]. 
 
  
                             (1)                                                               (2) 
  
                             (3)                                                               (4) 
Fig. 4.3.2 (1) Crystal structure (capped sticks style) of (±) carnegine, 1,2-Dimethyl-6,7-
dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, CSD refcode KORWOD; (2) 
Superimposition between KORWOD and E2; (3) Superimposition between KORWOD and E1; 
(4) Superimposition between KORWOD and meso.  
Superimpositions were performed by Accelrys Discovery Studio Client v 2.5.5.9350. 
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 In all three structures, the dimethoxy substituents are coplanar to the phenyl 
ring of the tetrahydroisoquinoline; the methyl groups pointing in opposite 
directions (see the torsion angles: C24-O1-C6-C7, C25-O2-C7-C6, C26-O3-C16-
C17 and C27-O4-C17-C16) Table 4.3.2. 
In all three crystal structures, the two 1,2,3,4-tetrahydropyridinium rings adopt 
a half-chair conformation with θ and Φ angles (see puckering parameters*, Table 
4.3.2) close to 60° and k × 60° [45-46]. As expected, change of the absolute 
configuration transforms θ into 180 - θ and Φ into 180 + Φ. 
In all three structures, atoms C21 and C23 substitute the chiral center atoms 
C10 and C20 on the axial position. The methyl groups also occupy the axial 
position on the protonated nitrogen for all three isomers. The relative position of 
those methyl groups with respect to the dimethoxy-tetrahydroisoquinolinium rings 
is however significantly different in the structures of E1 or E2 compared to the 
meso structure as a consequence of the conformation of the propyl linker (Fig. 
4.3.2). Indeed, conformation of the propane-diyl linker is all trans (t, t, t, t) for the 
meso structure while it is t, t, t, g for the separated stereoisomers E1 and E2 (see 
torsion angles N1-C10-C21-C22, C10-C21-C22-C23, C21-C22-C23-C20, and 
C22-C23-C20-N2). As a consequence, the relative orientation of the two 6,7-
dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium rings is similar in both E1 
and E2 but different from the one observed in the meso structure (Fig. 4.3.3).  
*For N-membered ring the puckering coordinates qm and Φm given by the equations:  
    (   )
   ∑       [      (   )  ]
     
     
(N odd   and    m=2, 3, . . ., (N-1)/2) 
    (   )
   ∑       [      (   )  ]
     
     
        (  )
     
(N even   and   m=2, 3, . . ., (N-2)/2 
zj  is the puckering displacement of  j
th
 atom from the least-squares plane. 
Total puckering amplitude Q is given by the equations:: 
   ∑   
 
  ∑   
  
     
For six-membered rings (N = 6), there are three puckering degrees of freedom. These are described by a single 
amplitude-phase pair (q2, Φ2) and a single puckering coordinate q3. Alternatively, these coordinates may be replaced 
by a spherical polar set (Q, θ, Φ),where Q is the total puckering amplitude and θ is an angle (0 ≤ θ ≤ π) such that 
q2 = Q sin θ 
q3 = Q cos θ                                                                                                                                                                             
(D. Cremer and J. A. Pople, A General Definition of Ring Puckering Coordinates, JACS, 1975, 97, 6, 1354-1358) 
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Table 4.3.2 Selected geometrical characteristics of the three crystal structures. 
Torsion angles (°) E1 Meso E2 
N1-C10-C21-C22 -173.3(2) 179.4(1) 173.7(2) 
C10-C21-C22-C23 172.4(2) -176.2(1) -172.0(2) 
C21-C22-C23-C20 63.0(2) -176.0(1) -63.2(3) 
C22-C23-C20-N2 -173.6(2) -155.4(1) 173.8(2) 
C24-O1-C6-C7 174.4(3) -176.7(2) -175.1(2) 
C27-O4-C17-C16 169.7(3) -174.7(2) -169.9(3) 
C26-O3-C16-C17 175.1(3) 174.8(2) -175.2(3) 
C25-O2-C7-C6 176.4(3) 178.8(2) -175.5(2) 
Ring puckering 
parameters 
E1 Meso E2 
Ring I [N1 > C10]    
Amplitude Q (Å) 0.494(2) 0.474(2) 0.494(3) 
θ (°) 49.6(2) 131.8(2) 130.1(3) 
Φ (°) 355.0(4) 180.3(3) 173.2(5) 
Ring II [N2 > C20]    
Amplitude Q (Å) 0.507(2) 0.486(2) 0.508(3) 
θ (°) 58.4(3) 46.7(2) 121.5(3) 
Φ (°) 337.7(4) 8.1(4) 157.2(5) 
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E1                                     E2                                   Meso 
Fig. 4.3.3 Crystal structure conformation (capped sticks style) shows the propane-diyl linker in 
the three isomers of 1,1'-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4 
tetrahydroisoquinolinum). H atoms, chlorine atoms and water molecules have been omitted for 
clarity. 
 
In particular, shorter inter-ring distances are observed in E1 and E2 compared to 
the meso structure. Indeed, centroids of the 6-membered benzene rings of the 
tetrahydropyridiniums are separated by 5.5 Å in the two SS or RR enantiomers 
(centroid distance = 5.541(2) Å and 5.535(2) Å and perpendicular distance of 
centroid to opposite ring =3.658 Å and 3.644 Å for E1 and E2 respectively) while 
the tetrahydroisoquinolinum rings are more tilted in the meso structure with a 
distance between centroids of the benzene rings of 5.897(1) Å (perpendicular 
distance of centroid to opposite ring = 5.221 Å). 
Crystal packing is also distinct in the meso crystal structure when compared to 
the E1 and E2 structures. In addition to the two chloride counter-ions, the meso 
structure also co-crystallized with five well defined water molecules that largely 
contribute to crystal packing through H-bonding (Table 4.3.3). However, in all 
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three structures, molecule/ions are arranged in layers of polar groups (protonated N 
cations, chloride ions and water molecules for the meso structure) alternating with 
stacked aromatic moieties (Fig. 4.3.4). The relative orientation of the different 
pharmacophoric elements (tetrahydroisoquinolinium rings, methyl substituent, and 
protonated nitrogen) is distinct between E1 or E2 and the meso structure and could, 
in part, explain the differences in biological affinities observed for the three 
isomers. Whether the close inter-ring contacts between the dimethoxy 
tetrahydroisoquinolinium rings is preserved upon binding to the receptor could be 
studied by molecular modeling starting from the crystal structure conformations. 
Table 4.3.3.Selected hydrogen bond geometries stabilizing crystal packing in the three crystal 
structures. For clarity, hydrogen bond network involving the water molecules has been simplified 
and only a selection of hydrogen bonds is presented. 
 E1 Meso E2 
N1‒H1N···Cl1i    
H···A (Å) 2.12 2.17 2.13 
D···A (Å) 3.020(2) 3.077(5) 3.025(5) 
D‒H···A (°) 169 170 169 
 i: x, y, -z i: x, 1/2 - y, 1/2 +z i: x, y, z 
N2‒H2N···Cl2ii    
H···A (Å) 2.13 2.20 2.14 
D···A (Å) 3.034(2) 3.102(4) 3.038(3) 
D‒H···A (°) 169 171 169 
 ii: x,y,z ii: x, y, z ii: x, y, z 
Ow1···Cl2iii    
D‒H (Å)  2.36  
D···A (Å)  3.174(5)  
D‒H ···A (°)  161  
  iii: -1 + x, 1/2 - y, -1/2 + z  
Ow2···Cl1iv    
D‒H (Å)  2.38  
D···A (Å)  3.212(5)  
D‒H···A (°)  165  
  iv: x, y, z  
Ow2···Cl2v    
D···H (Å)  2.41  
D···A (Å)  3.206(6)  
D‒H···A (°)  157  
  v: -1 + x, 1/2 - y, -1/2 + z  
- 144 - 
 
             
                   E1                                         E2                                        Meso 
Fig. 4.3.4 View of the packing of crystal structure E1 and E2 in b-direction and Meso in c-
direction showing the alternating layers of polar (protonated nitrogen atoms and chloride ions 
and water molecules for the Meso structure) and stacked aromatic dimethoxy 
tetrahydroisoquinoline rings. 
 
4.3.2  Crystal structure of Aegelinol 
Crystals of aegelinol (1) were obtained at room temperature by slow 
evaporation from a solution in ethanol. The structure belongs to the orthorhombic 
P212121 space group with cell parameters a = 6.8921(3) Å, b = 11.4302(9) Å, c = 
44.964(3) Å. The structure was solved by direct methods and refined to a final R1 
= 4.44%. Main statistics on data quality and refinement are given in Table 4.3.4. 
The coumarin moiety is planar with RMSDs of fitted atoms from the least-squares 
plane are 0.0247, 0.0396 and 0.0181 Å for the three molecules A, B and C, 
respectively. The dihedral angles between these planes in crystal packing are 
AˆA=2.65(3)°, AˆB = 13.39(3)°, BˆC = 2.99(4)° and AˆC =10.76(2)°. The bond 
lengths and bond angles observed in this structure are comparable with those 
reported for other coumarin derivatives in CSD (e.g., GEHWEW [47] and 
MOFJIA [48]). [Table 4.3.5] 
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Table 4.3.4. Main statistics on data quality and refinement for the crystal structures of aegelinol 
(1) and its inclusion complex in β-cyclodextrin (1-BCD). 
Crystallographic data Aegelinol β-CD-aegelinol 
Chemical formula of asymmetric 
unit 
3C14H14O4 
2C42H70O35. 
2C14H14O4.23.5H2O 
Temperature (K) 150 150 
Wavelength (Å) Mo Kα (0.71073) Cu Kα (1.54179) 
Crystal system Orthorhombic Triclinic 
Space group P212121 P1 
a (Å) 6.8921(3) 15.404(1) 
b (Å) 11.4302(9) 15.281(1) 
c (Å) 44.964(3) 17.890(1) 
α (°) 90.00 99.662(1) 
β (°) 90.00 113.423(1) 
γ (°) 90.00 102.481(1) 
Volume (Å
3
) 3542.2(4) 3618.4(5) 
Z 4 1 
Calculated density  (g.cm
-3
) 1.385 1.466 
F(0 0 0) 1560 1704 
Absorption coefficient (mm
-1
) 0.102 1.148 
Crystal description Long Rod Plate 
Crystal size (mm) 0.2 × 0.2 × 0.4 0.13 × 0.32 × 0.37 
Theta range for data collection (°) 3.25- 25.02 2.81-69.59 
Limiting indices 
-8 ≤ h ≤6  
-11 ≤ k ≤13 
 -46 ≤ l ≤53 
-18 ≤ h ≤14 
 -18 ≤ k ≤18  
-21 ≤ l ≤21 
Reflections collected/unique 10327/5883 36967/15938 
R (int) 0.0246 0.0355 
Data / restraints / parameters 5883 / 0 / 491 15938/88/2082 
Goodness-of-fit (S) on F
2
 1.097 1.060 
Refinement method 
Full-matrix least-squares on 
F
2
 
Full-matrix least-
squares on F
2
 
Final R indices [I>2sigma(I)] 4.44 % 6.71 % 
Final R indices (all data) 5.22 % 7.1 % 
Largest difference peak and hole 
(e/Å
3
) 
0.218 and -0.229 1.249* and -0.419 
Flack x parameter 0.4(9) 0.5(2) 
* The peak correspond to the density 1.249 is close to the methylene group at the primary side of 
cyclodextrin and it could be involved in disorder. 
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                          a                                                             b 
Figure 4.3.5 (a) Morphology of crystals of aegelinol (1) obtained by slow evaporation from a 
solution in ethanol; (b) Conformation of the three independent molecules in the asymmetric unit 
showing thermal motion (ORTEP, 30% probability). 
 
The packing of molecules in the unit cell gives some indication of the types of 
interaction that such a molecule would show in biological systems. Two types of 
interaction are found. First, the molecules are partially flat and pack in planes, 
where molecules A and its symmetrical equivalences are stacked one above the 
other in the opposite direction. B and C molecules have exactly the same 
arrangement as A molecules. The distances between these planes and the centroids 
of aromatic rings in the next layer are A-A = 3.481Å and B-C = 3.391Å. This 
arrangement allows optimal π-π interaction (Figure 4.3.6). Second, the carbonyl 
group interacts with hydroxyl groups in the next layer’s molecule with OH…O 
distances ranging from 2.816(2) to 2.903(3) Å, as shown in Figure 4.3.5, Table 
4.3.6. 
 Statistics of the Flack parameters (x = 0.4(9)) confirm that the absence of 
suitable heavy atoms (anomalous scatterers) in the molecule is a limitation for 
reliable absolute configuration of such molecules by X-ray diffraction [5].  
Crystal structure of the inclusion complex of aegelinol in β-cyclodextrin (1-
BCD) was also determined  (a = 15.404(1) Å, b = 15.281(1) Å, c = 17.890(1) Å,    
α = 99.662(1)°, β = 113.423(1)°,  γ = 102.481(1)°,  P1;  R1 = 6.71%)   and  allowed  
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Table 4.3.5. Selected structural features (bond lengths (Å), valence and torsion angles (°)) of the 
crystal structures of aegelinol (1, three molecules in asymmetric unit (A, B, C)) and its inclusion 
complex in β-cyclodextrin (1-BCD two molecules in asymmetric unit (A, B)). 
Geometrical aspects 1 A 1 B 1 C 1-BCD A 1-BCD B 
C6-C1` 1.503(3) 1.501(3) 1.501(3) 1.488(15) 1.52(2) 
C1`- C2` 1.518(4) 1.523(4) 1.520(4) 1.451(19) 1.49(3) 
C2`- O2` 1.431(3) 1.422(3) 1.429(3) 1.425(15) 1.43(2) 
C2`- C3` 1.522(4) 1.527(4) 1.521(4) 1.52(2) 1.45(3) 
C3`- O3` 1.463(3) 1.470(3) 1.467(3) 1.461(15) 1.50(2) 
C7- O3` 1.363(3) 1.361(3) 1.34(2) 1.350(14) 1.36(2) 
C7-C6- C1` 120.0(2) 120.0(2) 120.1(2) 120.8(11) 120.4(15) 
C6- C1`- C2` 110.4(2) 111.6(2) 110.2(2) 110.4(10) 113.4(17) 
O2`- C2`- C1` 111.4(2) 111.8(2) 111.3(2) 109.8(10) 114.3(17) 
C1`- C2`- C3` 110.3(2) 110.7(2) 110.6(2) 113.6(12) 111.7(17) 
O3`- C3`- C2` 109.7 (2) 109.7(2) 110.6(2) 106.2(11) 113.6(14) 
O3`-C7-C6 122.9(2) 123.0(2) 123.2(2) 122.4(11) 124.5(13) 
C7- O3`- C3` 118.6 (2) 118.4 (2) 119.0(2) 117.6(11) 114.3(13) 
C5-C6- C1`- C2` -156.9(2) -159.3(2) -154.0(2) -164.5(9) 170.3(15) 
C7-C6- C1`- C2` 21.4(3) 20.5(3) 24.7(3) 13.9(13) -10(3) 
C6- C1`- C2`- O2` 70.3(3) 79.0(3) 71.9(3) -172.1(10) -78(3) 
C6- C1`- C2`- C3` -50.4(3) -47.1(3) -50.8(3) -45.7(14) 37(3) 
O2`- C2`- C3`- O3` -62.3(3) -67.7(3) -65.7(3) -172.7(10) 67.6(17) 
C1`- C2`- C3`- O3` 60.0(3) 58.2(3) 57.7(3) 62.1(13) -55(2) 
O2`- C2`- C3`- C4` 177.6(2) 172.2(2) 173.7(2) 
-59.8(14), 
69.3(15) 
-175.5(13), 
-52.8(19) 
C1`- C2`- C3`- C4` -60.0(3) -62.0(3) -62.9(3) 
175.0(11), 
-55.9(15) 
62(2), 
-175.1(19) 
C1`-C6-C7- O3` -0.4(4) -4.0(4) -4.3(4) 0.5(14) 0(2) 
C8-C7- O3`- C3` -172.5(2) -166.6(2) -172.4(2) -162.8(9) 162.0(13) 
C6-C7- O3`- C3` 10.1(3) 15.8(3) 11.0(4) 18.0(15) -16(2) 
C2`- C3`- O3`-C7 -39.6(3) -42.6(3) -37.6(3) -46.6(14) 44(2) 
C4`- C3`- O3`-C7 82.3(3) 79.1(3) 84.9(3) 
-164.9(11), 
74.9(14) 
-77.0(19), 
171.8(19) 
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(a)                                                                (b)                   
  
 
 
(c) 
 
Figure 4.3.6. Crystal packing of aegelinol. (a) Stacking along the a axis; (b) Stacking along the b 
axis; (c) π-π stacking distances (Å) in aegelinol alone. 
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Table 4.3.6. Selected hydrogen bonds in aegelinol alone and in the complex with β-cyclodextrin. 
Aegelinol (1) 
D A d (D-H) (Å) d (H...A) (Å) d (D...A) (Å) <(DHA) (°) 
O(2`A) O(2A)i 0.840 2.080 2.902 164.5 
O(2`B) O(2C)ii 0.840 2.010 2.816 159.4 
O(2`C) O(2B) 0.840 2.030 2.851 165.8 
BCD-1 complex (1-BCD) 
O2´A1 O13W 0.840 2.122 129.16 2.731 
O2´B1 O61A 0.840 2.524 150.01 3.278 
O2´A2 O17'W 0.840 1.824 134.51 2.487 
O2´B2 O63Biii 0.840 2.065 151.37 2.831 
O65A  O2´A2vii 0.840 2.424 98.20 2.729   
O31A O31B 0.840 1.969 173.10 2.804 
O22A O37B 0.840 2.289 148.87 3.039 
O22A O18'Wii 0.840 2.607 143.00 3.316 
O32A O37B 0.840 1.863 166.02 2.686 
O62A O17Wiii 0.863 1.935 147.92 2.705 
O62A O17'Wiii 0.863 2.012 175.31 2.873 
O23A O36B 0.840 2.404 150.53 3.162 
O24A O35B 0.840 2.281 142.75 2.993 
O64A O67Aiv 0.840 2.261 126.43 2.841 
O25A O7Wv 0.840 2.408 125.26 2.973 
O35A O34B 0.840 1.970 171.85 2.804 
O36A O18'W 0.840 1.974 138.08 2.659 
O66A O62Avi 0.840 2.117 133.75 2.765 
O27A O46A 0.840 2.388 111.57 2.807 
O67A1 O24W 0.840 2.499 154.48 3.277 
O67A2 O20Wvii 0.840 2.627 161.97 3.436 
O32B O37A 0.840 1.934 164.80 2.753 
O62B O65Bviii 0.840 2.140 132.42 2.777 
O23B O42B 0.840 2.279 114.51 2.736 
O33B O36A 0.840 1.938 162.04 2.749 
O63B O3Wvi 0.840 1.865 176.56 2.704 
O24B O35A 0.840 2.508 135.02 3.159 
O24B O26A 0.840 2.630 110.55 3.029 
O64B O51Aix 0.840 2.196 169.12 3.025 
O64B O61Aix 0.840 2.220 116.96 2.707 
O35B O34A 0.840 1.924 154.65 2.707 
O26B O33A 0.840 2.434 148.31 3.180 
O36B O33A 0.840 1.923 168.68 2.751 
O66B O24Wx 0.840 2.576 124.04 3.124 
O27B O32A 0.840 2.373 133.66 3.015 
O67B O63Bii 0.840 1.957 162.82 2.770 
O21B O18Wii 0.840 2.349 154.82 3.129 
O65A O19W 0.840 2.405 127.62 2.993 
O13W O21Wxi 0.848 1.948 149.22 2.712 
O13W O19Wxii 0.842 1.905 156.68 2.700 
Symmetry: i [x-1/2, -y+3/2, -z+2]; ii [x+1, y, z]; iii [x+1, y, z+1]; iv [x, y-1, z]; v [ x-1, y-1, z]; vi 
[x-1, y, z];  vii [x, y, z+1]; viii[ x, y+1, z]; ix  [ x-1, y-1, z-1]; x [x, y-1, z-1]; xi[ x-1, y, z-1]; xii [x, 
y, z-1]. 
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unambiguous determination of the absolute configuration of the stereogenic center 
of aegelinol. Crystals were grown from a solution in water/ethanol (50:50). Two 
morphologies of crystals are observed: the long and yellow crystals (analyzing the 
cell parameters on the diffractometer showed that it correspond to the aegelinol 
alone), and parallelepiped and colorless ones are related to the inclusion complex 
with β-cyclodextrin. Primary statistics on data quality and refinement are given in 
Table 4.3.4.  
Figure 4.3.7 presents the structure of the inclusion complex. From this 
structure, the absolute configuration of C2’ of aegelinol can unambiguously be 
assigned and corresponds to the (R) enantiomer.  
Interestingly, disorder of the included aegelinol molecule within the 
cyclodextrin cavity was modeled in two sites, nearly similar, with 60:40 
occupancy. The coumarin moieties are planar with RMSDs of fitted atoms from 
the least-squares plane are 0.0034 and 0.0038 Å for the two molecules A and B, 
respectively. The dihedral angles between these planes, inside the cavity, is 
22.2(4)° in the first site and 3.0(3)° in the second site. 
 
(a) 
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(b) 
 
(c) 
Figure 4.3.7. (a) Morphology of crystals of aegelinol - β-cyclodextrin inclusion complex (1-
BCD). Two forms of crystals are observed: (I) corresponds to cell parameters of aegelinol alone 
and (II) corresponds to cell parameters of the inclusion complex. (b) Two perpendicular views 
showing the conformation of the 1-BCD inclusion complex (ORTEP, 30% probability) and 
confirming the R configuration at C2’. Only one component of the disorder of the guest 
molecule inside the cyclodextrin cavity is presented and hydrogen atoms and water molecules 
are removed for clarity. (c) View of the two aegelinol molecules after removing all the rest of the 
structure to show their configuration. 
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The solution of the crystal structure revealed a 2:2 stoichiometry. The 
pyranocoumarin guest is included within the cylindrical cavity formed by dimeric 
β-cyclodextrin molecules with a head-to-head arrangement. Crystalline complexes 
of hydrogen-bonded β-cyclodextrin dimers complexed with organic guest 
molecules have been found previously to adopt one of four crystal packing motifs: 
a channel motif (Ch), a checker board motif (CB), an intermediate motif (Im), and, 
most recently, a tetrad motif (Tt). Packing diagrams are available in different 
reports on β-cyclodextrin complexes; the reader is referred to these works for both 
diagrams and discussion of the different structural properties for these packing 
arrangements [49–51]. 
 
 The CD host molecules are associated through hydrogen bonding between 
secondary hydroxyl groups as dimers, packing in the previously observed (Im) 
packing arrangement [49–51]. The fact that this arrangement is common to these 
complexes of β-CD is important for two reasons: 
(1) It implies that crystal packing does not severely limit conformational and              
translational freedom of guest molecules. 
(2) It provides an environment for the guest molecules that resembles a 
macromolecular binding pocket by providing a hydrophobic pocket rimmed with a 
scaffolding of hydrophilic binding sites that can interact directly with guest 
molecules or via bridging water molecules. 
As a consequence, guest molecules experience considerable variation in their 
specific interactions with the host molecules and waters of hydration, often 
resulting in the observation of crystallographic disorder. This semichannel-type 
packing orients along the c-axis direction (Figure 4.3.8.). 
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a                                     c                                        b 
Figure 4.3.8. Crystal packing of β-cyclodextrins in the 1-BCD crystal structure shown along the 
a, b and c directions. Guest molecules (aegelinol) and waters are omitted for clarity. 
 
 
One hydrogen bond is observed between the cyclodextrin and the first site and 
two in the second site of the disordered guest (Table 4.3.7 and Figure 4.3.9). These 
hydrogen bonds are between the hydroxyl groups on the guest and on the primary 
side of cyclodextrin. The two molecules of aegelinol stack together (mainly 
involving the coumarin moieties) and are stabilized by hydrophobic effect within 
the cavity formed by two cyclodextrins (Figure 4.3.7). The distances between the 
planar coumarin and the centroid of the other coumarin are 3.233Å in the first site 
and 3.215 Å in the second site. Moreover, this arrangement serves a strong π-π 
interaction (Figure 4.3.10). Notable differences are observed at the level of the 
pyroano ring of the two aegelinol molecules (RMSD = 0.871 Å and Table 2) most 
likely resulting from less constraints in 1-BCD compared to the structure of 1 
alone. Twenty-four ordered water molecules are also observed in the structure. 
They are situated outside the cavity at the borders of the toroid rims and in 
interstices between β-CD molecules. Five water molecules are disordered over two 
sites. 
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Molecule A first disorder                               Molecule B first disorder 
                
Molecule A second disorder                      Molecule B second disorder 
 
Figure 4.3.9. The involved hydrogen bonds in aegelinol in both disorder sites Symmetry 
transformations used to generate equivalent atoms: iii [x+1, y, z+1]; iv [x, y, z+1]. 
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a                                                                b  
Figure 4.3.10. π-π stacking distances (Å) in aegelinol-β-CD complex. (a) In first site; (b) In 
second site. 
 
4.4 Experimental Section  
4.4.1 Chemistry 
Synthesis and purification of 1,1'-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-
methyl-1,2,3,4-tetrahydroisoquinolinum) hydrochloride salt were performed by the 
group of Prof. J.-F. Liégeois at the University of Liège (ULg). The Compounds 
were obtained following the procedure detailed in reference [52]. Briefly, under 
inert atmosphere, NaBH4 (1.76 g; 46.5 mmol) was added to a solution of the 1,3-
bis[1-(6,7-dimethoxy-2-methylisoquinolylium)]-propane diiodide [10] (1.85 g; 3.1 
mmol) in MeOH (100 mL) at room temperature. After 15 min, MeOH was 
removed under reduced pressure and the crude residue was dissolved in a 1 N 
aqueous HCl (100 mL). The acidic layer was washed with Et2O (3 × 20 ml) and 
then basified with NH4OH. The suspension was extracted with CH2Cl2 (3 × 30 
mL). The organic layers were collected, dried over anhydrous MgSO4 and 
evaporated under reduced pressure to afford colorless oil which was purified by 
flash chromatography on Kieselgel with a mixture of Me2CO/MeOH (9/1, v/v) as 
mobile phase. The purified oily derivative was isolated as hydrochloride salt. 
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Separation of the three enantiomers as base was performed by semi-preparative 
chiral HPLC using a Chiralcel
®
 OD-H column and a mixture of 2-propanol 
(80)/hexane (20) containing 0.05% diethylamine at a flow rate of 1 mL/min [52]. 
Isolation and purification of aegelinol (1) has been performed by the group of 
Prof. Thierry Hennebelle at Université Lille Nord de France Lille2 [11]. Briefly, 
roots of F. asparagifolia (500 g) were dried, powdered and extracted successively 
with light petroleum, EtOAc and MeOH at room temperature. Extracts were then 
evaporated and lyophilized. The EtOAc extract (4.0 g) was chromatographed over 
silica gel columns. Six compounds were isolated from the EtOAc extract, one of 
which corresponding to aegelinol.  
4.4.2 X-ray studies 
All the crystallization, the data collection and the crystallographic analyzing 
procedures have been done in our laboratory (CBS) at the University of Namur 
(UNamur). 
Crystals of the three stereoisomers E1, E2 and Meso of the 1,1'-(propane-1,3-
diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinum) hydrochloride 
salts were obtained by slow evaporation from an acetonitrile solution. X-ray 
measurements were performed on a Gemini Ultra R system (4-circle kappa 
platform, Ruby CCD detector) using Mo Kα radiation (λ=0.71073 Ǻ) for all three 
compounds (E1, E2 and Meso-1,10-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-
methyl-1,2,3,4-tetrahydroisoquinoline) hydrochloride. After mounting and 
centering of the single crystals on the diffractometer, cell parameters were 
estimated from a pre-experiment run and full datasets collected at room 
temperature. Software for data reduction was CrysAlisPro [53]. Structures were 
solved by direct methods from SHELXS-97 program and then refined on F
2
 using 
SHELXL-97 software [54]. Datasets for E1 and E2 were filtered in order to retain 
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reflections above theta=25° (resolution > 0.84 Ǻ). Non-hydrogen atoms were 
anisotropically refined and the hydrogen atoms in the riding mode with isotropic 
temperature factors fixed at 1.2 times U (eq) of the parent atoms (1.5 times for 
methyl groups). Structures contain residual solvent accessible void of about 35 Ǻ3 
that could accommodate a water molecule that was not explicitly included in the 
refinements. Thermal agitation is higher for atoms C3 and C13 than for 
neighboring atoms. 
Crystals of aegelinol were prepared by dissolving a 1–2 mg amount of 
aegelinol in a minimal amount of ethanol. The mixture was then stored at room 
temperature. Colorless long crystals suitable for X-ray data collection were 
obtained by slow evaporation after one week. 
Crystals of the β-CD in complex with aegelinol were prepared by dissolving a 
few milligrams of β-CD in water (2 mL) at 65 °C and aegelinol in ethanol (2 mL) 
at 65 °C, in stoichiometric (2:1) ratio with respect to β-CD. Both solutions were 
mixed and stirred at 65 °C for 6 hours. Then the mixture was stored at room 
temperature. Two forms of crystals (colorless plates and pale yellow needle) 
suitable for X-ray data collection were obtained by slow evaporation after one 
week. 
Single crystals of aegelinol and of the β-CD-aegelinol complex were mounted 
on the head of a 4-circle kappa goniometer. X-ray diffraction experiment was 
carried out at low temperature (150 K) on an Oxford Gemini R Ultra using Mo Kα 
(λ=0.71073 Å) (aegelinol) or Cu Kα (λ=1.54179 Å) radiation (inclusion complex). 
Data reduction was carried out with the CrysAlisPro program [53]. Crystal data 
collection and refinement details are listed in Table 4.3.4. 
The structure of aegelinol was determined by direct methods and refined using 
full-matrix least-squares based on F
2
 with the program SHELX [54], based on 491 
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parameters and 0 restraints. The refinement converged to R1 = 4.44% for I > 2σ(I) 
and 5.22% for all data. Hydrogen atoms were calculated at ideal positions and 
refined using a riding model. 
The structure of the β-CD-aegelinol complex was solved by atomic 
coordination replacement methods using a β-CD complex structure from CSD 
[BOSZOZ] [55] with the same cell parameters after making suitable 
transformation and deleting the guest from the structure. Extra electronic density in 
the cavity corresponded to aegelinol. This structure was refined using full-matrix 
least-squares on F
2
 with the program SHELX [54], based on 2083 parameters and 
89 restraints. The refinement converged to R1 = 6.71% for I > 2σ(I) data and 7.10% 
for all data. Most hydrogen atoms were calculated at ideal positions and refined 
using a riding model and the rest of the hydrogen atoms were located on a different 
Fourier map. Ordered water molecules were located in a difference Fourier map. 
All non-hydrogen atoms were anisotropically refined. Secondary hydroxyl groups 
were refined with two alternate conformations. Disorder of the included aegelinol 
molecules within the cyclodextrin cavity, five disordered water molecules and two 
primary hydroxyl groups in β-CD were modeled in two sites. The second sites 
were located from difference Fourier maps. 
Coordinates have been deposited at the Cambridge Structure DataBank 
(CCDC 754726, 754727 and 754728 contain the supplementary crystallographic 
data of E1, E2 and Meso, CCDC 884098 and 884099 contain the supplementary 
crystallographic data of aegelinol and aegelinol-β-cyclodextrin complex), and can 
be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from 
the Cambridge Crystallographic Data Centre,12, Union Road, Cambridge CB2 
1EZ, UK; fax: +44 1223 336033; or deposit@ccdc.cam.ac.uk). 
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4.5 Conclusions  
Crystal structures of the stereoisomers of 1,10-(propane-1,3-diyl)-bis-(6,7-
dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline) hydrochloride obtained after 
resolution by semi-preparative chiral HPLC (Chiralcel
®
 OD-H column) establishes 
the absolute configuration of the separated compounds. The first peak (7 min) 
corresponds to a first enantiomer (E1) with absolute configuration S,S for C10, 
C20. [ ] 
   of the first eluted enantiomer is +34.8°. The second eluted peak (10 
min) corresponds to the meso form (formally an R,S and S,R). The third eluted 
peak (23 min), corresponding to the E2 enantiomer, is the mirror image of the first 
enantiomer, with an R,R configuration for C10, C20 and [ ] 
   of -34.5°. The 
conformation and precise configuration of the molecules deduced from our 
crystallographic study, by mean of Flack parameters, will serve as starting point 
for further molecular modeling simulation planned to rationalize the differences in 
affinity of the series for small conductance Ca
2+
-activated K
+
 (SK) channels. 
Crystals of aegelinol (1) alone were obtained and led to determination of its 
crystal structure. Statistics of the Flack parameters confirm that the absence of 
suitable heavy atoms (no strong anomalous scatterers) in the molecule is a 
limitation for reliable absolute configuration of such molecules by X-ray 
diffraction. Derivatization of the molecule by formation of a chiral salt was not an 
alternative as the molecule does not contain any basic or acidic function. As an 
alternative, we were able to grow crystals of the inclusion complex of aegelinol in 
β-cyclodextrin and refined the crystal structure of the complex, which allowed 
unambiguous determination of the absolute configuration of the stereogenic center 
of aegelinol. The (R) configuration of C2’ obtained by this crystallographic study 
confirms previous conclusions based on indirect NMR data. 
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Chapter 5 
Conclusion and perspectives 
 
The main objective of this thesis was to design, prepare and characterize new 
crystal systems containing cyclodextrins in combination with:  
1) Para aminobenzoic acid as a drug model to study the effect of complexation 
phenomena on the solubility of drugs and characterize their structure and 
mode of interaction by combination a theoretical and experimental approach. 
2) Potassium hydroxide to prepare cyclodextrin Metal-Organic Frameworks 
(CD-MOFs) formed by coordinating the cyclodextrins to potassium cation. 
Consequently taking the advantages of this interaction between cyclodextrin 
and alkali metal cation to favour formation of inclusion complexes as CD-
MOFs drug carrier.   
3) Aegelinol, a natural product, for analytical purposes to determine the absolute 
configuration of this compound by formation of an inclusion complex with a 
host of known chirality (cyclodextrins consists of several optically active D-
glucose units). This should allow direct determination of the absolute 
configuration of the guest (aegelinol). 
5.1  pABA-α-CD inclusion complex 
Our crystallography study shows that pABA forms a 1:1 complex with α-CD 
and is deeply included into the cavity of the cyclodextrin, with the amino group 
protruding from the wide site of the cavity and the (unprotonated) carboxylate at 
the narrow side [Figure 5.1-a]. The crystal structure corresponds to the anionic 
form of pABA. The pABA guest is held in the host cavity mainly by van der Waals 
contacts and hydrogen bonds.  Spectroscopic studies of the interactions of pABA 
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with α-CD demonstrate the insertion of pABA into the Cyclodextrin cavity in 
solution, with formation of a 1:1 inclusion complex with stability constant 
2319.4±241.0 M
-1
 at 25°C and pH=3.5 [Figure 5.1-b]. The phase solubility studies 
confirm the formation of a 1:1 pABA-α-CD inclusion complex. The solubility of 
pABA in water is markedly enhanced by complexation with α-CD. The 
calculations carried out with the PM6 method show that inclusion complexes of 
different pABA protonation states with α-CD lead to stable structures and this 
confirms experimental observations. During this theoretical study, orientation A 
(carboxylic group inside) was more favorable than orientation B (amino group 
inside), in agreement with our crystal structure. 
       
a                                                              b 
Figure 5.1 a) Axial view of the X-ray structure of the 1:1 host-guest inclusion complex of α-
Cyclodextrin (α-CD) and p-Aminobenzoic acid (pABA). b) Absorption spectra of pABA 5×10-5 
M at pH=3.5 in absence and presence of different concentrations of α-CD. 
5.2 CD-MOFs 
The interaction between potassium cations and α-CD has been established and 
well characterized in the crystalline state [Figure 5.2-a]. The structure shows 3D 
MOFs architecture and α-CD adopts a cage crystal structure packing stabilized, 
mainly, by coordinating the potassium cation through the ‒OCCO‒ motifs, in 
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addition to intermolecular and intramolecular hydrogen bondings. A new morph of 
α-CD belonging to the tube crystal structure packing form has also been 
accidentally established during the attempt to produce an inclusion complex with 
mABA and oABA. This new morph has a potential application in the field of gas 
storage and molecular absorption. Although present during crystallization, the 
“guest” mABA or oABA is not present in the crystal. Its presence is essential to 
obtain this polymorphic form and requires more investigation. A new technique 
was found to prepare a drug carrier based on the cyclodextrins by relying on their 
ability to form MOFs with alkali metals cations. These CD-MOFs possess a 
hydrophobic cavity able to receive the drug molecule inside. Two MOFs were 
prepared by this technique between α-CD and K+mABA- or K+oABA- showing 1D 
MOFs where K
+
 cations assist in the assembly of two α-CD molecules to form a 
box containing a guest inside the cavity [Figure 5.2-b,c]. 
    
a                                     b                                      c 
Figure 5.2 a) 1:2 complex of α-CD with KOH. b,c) The structures of α-cyclodextrin MOFs with 
m-aminobenzoate potassium(b) and o-aminobenzoate potassium(c), respectively. 
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5.3 Experimental absolute configuration determination   
Crystals of aegelinol (1) [Figure 5.3-a] alone were obtained and led to 
determination of its crystal structure [Figure 5.3-b]. Statistics of the Flack 
parameters confirm that the absence of suitable heavy atoms (no strong anomalous 
scatterers) in the molecule is a limitation for reliable absolute configuration of such 
molecules by X-ray diffraction. Derivatization of the molecule by formation of a 
chiral salt was not an alternative as the molecule does not contain any basic or 
acidic function. As an alternative, we were able to grow crystals of the inclusion 
complex of aegelinol in β-cyclodextrin and refined the crystal structure of the 
complex [Figure 5.3-c], which allowed unambiguous determination of the absolute 
configuration of the stereogenic center of aegelinol. The (R) configuration of C2’ 
obtained by this crystallographic study confirms previous conclusions based on 
indirect NMR data. 
 
a 
                        
b                                                          c 
Figure 5.3 a) The chemical structure and numbering scheme of aegelinol. b) Crystal structure of 
aegelinol alone, three molecules in the crystal structure (A, B and C). c) Crystal structure of 
aegelinol in complex with β-CD. 
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5.4 Perspectives 
Smaldone et al. suspected that the key to their success in assembling CD-
MOFs lies in the symmetric arrangement (C8) within the γ-CD torus of eight 
asymmetric (C1) α-1,4-linked D-glucopyranosyl residues and the ready availability 
of γ-CD as a chiral molecular building block [1-2]. But this is not the only 
condition in the success in building useful porous CD-MOFs. Indeed we got a new, 
highly porous, structure, starting from β-CD and KOH by the same simple 
procedure as the one described for γ-CD-MOFs. This structure is as important as 
those designed by γ-CD. However, we failed to obtain a similar porous structure 
starting from α-CD despite the fact that α-CD has a symmetrical structure largely 
similar to the γ-CD symmetry while β-CD has not. We followed the same 
procedure as was done in preparation of γ-CD-MOFs by combining a suitable 
molar ratio of CD and KOH.   
In case of β-CD, we got two forms of crystals with the same condition. The 
first form, with a parallelepiped shape and grown equally in three dimensions [Fig 
5.4.1- a], forms the majority of resulting crystals. It corresponds to a structure 
already known in literature with stoichiometry 1(β-CD):1(K+) [3]. This complex 
crystallizes in P21 monoclinic space group [cell parameters: a = 15.223(5)Å, b = 
10.578(3)Å, c = 20.204(6)Å, α = 90°, β = 108.37(7)° and γ = 90°]. In this 
structure, β-CD molecules form, through the 21 axis, a herringbone-like pattern 
along the bc plan and the potassium cations are trapped in the lattice external to the 
β-CD cavity. Every β-CD molecule is connected to the adjacent β-CD molecules  
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                             a                                                               b 
Figure 5.4.1 Two crystal morphs of β-CD-KOH complex: a) β-CD-KOH (1:1) complex, b) β-
CD-KOH (1:2) complex. 
by four K
+
 cations and every K
+
 cation is surrounded by four β-CD molecules and 
one water molecule [Fig 5.4.2-a,b]. In general, this structure is rather similar to the 
structure of β-CD alone [P21 in monoclinic system: a = 21.29(2) Å, b = 10.33(1) Å, 
c= 15.10(2) Å, α = 90.0°, β = 112.3(5) °, γ = 90.0°] [4]. The two structures  have, 
approximately, the same cell parameters,  the same distribution and stacking form 
within the unit cell [Fig 5.4.2-c,d,e], suggesting that some water molecules have 
been replaced by K
+
 cations. As a result this structure might be the most favorable 
energetically.  
                          
a                                                        b 
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c                                          d                                         e 
Figure 5.4.2 a) 1:1 complex of β-CD with KOH , b) Potassium coordination , c) , d) and e) 
Crystal packing, in α-CD-KOH complex, in a, b and c direction respectively. 
 
In parallel, we found a few number of different crystal forms with a rod-like 
shape [Fig 5.4.1-b]. The structure belongs to a new β-CD-KOH-MOF with 
stoichiometry 1(β-CD):2(K+) [Fig 5.4.3-a,-b]. This complex crystallizes in R32 
hexagonal crystal space group [cell parameters: a = 41.525(2) Å, b = 41.525(2) Å, 
c = 27.1197(16) Å, α = 90°, β = 90° and γ = 120°].  
In this structure, β-CD molecules are linked together by potassium cations to 
form a hexagonal ring, where potassium cations occupy the corners of two parallel 
regular hexagons separated by a distance of 9.04 Å. The β-CD molecules form the 
sides with dihedral angle between their glucosidic plans and the potassium cations 
hexagon plan of 52.95° and 62.05°. This generates an empty space with a diameter 
of about 28 Å (2.8 nm) [Fig 5.4.3-c,-d]. Theoretical calculation of void volume 
inside the structure, using the contact surface with a 1.2 Å probe radius in Mercury 
software, shows an approximate value for the void volume about 19166 Å
3
 and 
equal to 47.3 % of the structure. The overall stacking arrangement in the crystal 
structure displays winding channels in three directions and opened to each other 
[Fig 5.4.3-e]. This might give the new structure potential applications, in the field 
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of gas storage and molecular absorption. This requires to be more investigated. 
Also the conditions that lead to the formation of this MOF will have to be adjusted. 
 
           
a                                                             b 
          
c 
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e 
Fig 5.4.3 a, b) Potassium coordination, c) 1:2 complex of β-CD with KOH, d) Definition of the 
two parallel regular hexagon plans and the separated distance, e) crystal packing in c-direction 
showing the contact surface calculated by a 1.2 Å probe. 
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